{"subnetworks": [{"diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY", "NEUROPATHY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "CHRONIC PANCREATITIS", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "COUGH", "GENICULATE HERPES ZOSTER", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY", "MIGRAINE DISORDER", "ANXIETY", "RENAL INSUFFICIENCY", "INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "STROKE", "SUBARACHNOID HEMORRHAGE", "ANAL FISSURE", "KIDNEY STONE", "PARKINSON'S DISEASE", "BIPOLAR DISORDER", "CONSTIPATION", "SKIN DISEASE", "ANGINA PECTORIS", "HYPERTENSION", "INTRACEREBRAL HEMORRHAGE", "CORONARY ARTERY DISEASE", "PROTEINURIA", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "ATRIAL FIBRILLATION", "LIVER DISEASE", "UNIPOLAR DEPRESSION", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS", "GAMBLING BEHAVIOUR", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "OBSESSIVE-COMPULSIVE DISORDER", "SCHIZOPHRENIA", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "MOVEMENT DISORDER", "GLIOBLASTOMA MULTIFORME", "FEVER", "ALCOHOL DRINKING", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "OBESITY", "SMOKING CESSATION", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "TORTICOLLIS", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AUTISM SPECTRUM DISORDER", "DIABETIC RETINOPATHY"], "links": [{"source": "ENSG00000006116", "target": "ENSG00000006283"}, {"source": "ENSG00000006116", "target": "ENSG00000067191"}, {"source": "ENSG00000006116", "target": "ENSG00000075429"}, {"source": "ENSG00000006116", "target": "ENSG00000075461"}, {"source": "ENSG00000006116", "target": "ENSG00000081248"}, {"source": "ENSG00000006116", "target": "ENSG00000102001"}, {"source": "ENSG00000006116", "target": "ENSG00000105605"}, {"source": "ENSG00000006116", "target": "ENSG00000108878"}, {"source": "ENSG00000006116", "target": "ENSG00000116032"}, {"source": "ENSG00000006116", "target": "ENSG00000130433"}, {"source": "ENSG00000006116", "target": "ENSG00000142408"}, {"source": "ENSG00000006116", "target": "ENSG00000148408"}, {"source": "ENSG00000006116", "target": "ENSG00000151062"}, {"source": "ENSG00000006116", "target": "ENSG00000151067"}, {"source": "ENSG00000006116", "target": "ENSG00000152578"}, {"source": "ENSG00000006116", "target": "ENSG00000153956"}, {"source": "ENSG00000006116", "target": "ENSG00000157388"}, {"source": "ENSG00000006116", "target": "ENSG00000165995"}, {"source": "ENSG00000006116", "target": "ENSG00000166862"}, {"source": "ENSG00000006116", "target": "ENSG00000167535"}, {"source": "ENSG00000006116", "target": "ENSG00000176884"}, {"source": "ENSG00000006116", "target": "ENSG00000182389"}, {"source": "ENSG00000006116", "target": "ENSG00000183454"}, {"source": "ENSG00000006116", "target": "ENSG00000196557"}, {"source": "ENSG00000006116", "target": "ENSG00000198216"}, {"source": "ENSG00000006116", "target": "ENSG00000198785"}, {"source": "ENSG00000006283", "target": "ENSG00000067191"}, {"source": "ENSG00000006283", "target": "ENSG00000081248"}, {"source": "ENSG00000006283", "target": "ENSG00000100346"}, {"source": "ENSG00000006283", "target": "ENSG00000102001"}, {"source": "ENSG00000006283", "target": "ENSG00000105605"}, {"source": "ENSG00000006283", "target": "ENSG00000108878"}, {"source": "ENSG00000006283", "target": "ENSG00000130433"}, {"source": "ENSG00000006283", "target": "ENSG00000142408"}, {"source": "ENSG00000006283", "target": "ENSG00000148408"}, {"source": "ENSG00000006283", "target": "ENSG00000151062"}, {"source": "ENSG00000006283", "target": "ENSG00000151067"}, {"source": "ENSG00000006283", "target": "ENSG00000153956"}, {"source": "ENSG00000006283", "target": "ENSG00000157388"}, {"source": "ENSG00000006283", "target": "ENSG00000165995"}, {"source": "ENSG00000006283", "target": "ENSG00000166862"}, {"source": "ENSG00000006283", "target": "ENSG00000167535"}, {"source": "ENSG00000006283", "target": "ENSG00000182389"}, {"source": "ENSG00000006283", "target": "ENSG00000196557"}, {"source": "ENSG00000006283", "target": "ENSG00000198216"}, {"source": "ENSG00000007402", "target": "ENSG00000067191"}, {"source": "ENSG00000007402", "target": "ENSG00000108878"}, {"source": "ENSG00000007402", "target": "ENSG00000141837"}, {"source": "ENSG00000007402", "target": "ENSG00000182389"}, {"source": "ENSG00000067191", "target": "ENSG00000075461"}, {"source": "ENSG00000067191", "target": "ENSG00000081248"}, {"source": "ENSG00000067191", "target": "ENSG00000100346"}, {"source": "ENSG00000067191", "target": "ENSG00000102001"}, {"source": "ENSG00000067191", "target": "ENSG00000105605"}, {"source": "ENSG00000067191", "target": "ENSG00000108878"}, {"source": "ENSG00000067191", "target": "ENSG00000130433"}, {"source": "ENSG00000067191", "target": "ENSG00000141837"}, {"source": "ENSG00000067191", "target": "ENSG00000142408"}, {"source": "ENSG00000067191", "target": "ENSG00000148408"}, {"source": "ENSG00000067191", "target": "ENSG00000151062"}, {"source": "ENSG00000067191", "target": "ENSG00000151067"}, {"source": "ENSG00000067191", "target": "ENSG00000153956"}, {"source": "ENSG00000067191", "target": "ENSG00000157388"}, {"source": "ENSG00000067191", "target": "ENSG00000165995"}, {"source": "ENSG00000067191", "target": "ENSG00000166862"}, {"source": "ENSG00000067191", "target": "ENSG00000167535"}, {"source": "ENSG00000067191", "target": "ENSG00000182389"}, {"source": "ENSG00000067191", "target": "ENSG00000196557"}, {"source": "ENSG00000067191", "target": "ENSG00000198216"}, {"source": "ENSG00000075429", "target": "ENSG00000075461"}, {"source": "ENSG00000075429", "target": "ENSG00000105605"}, {"source": "ENSG00000075429", "target": "ENSG00000116032"}, {"source": "ENSG00000075429", "target": "ENSG00000142408"}, {"source": "ENSG00000075429", "target": "ENSG00000152578"}, {"source": "ENSG00000075429", "target": "ENSG00000166862"}, {"source": "ENSG00000075429", "target": "ENSG00000176884"}, {"source": "ENSG00000075429", "target": "ENSG00000183454"}, {"source": "ENSG00000075429", "target": "ENSG00000198785"}, {"source": "ENSG00000075461", "target": "ENSG00000105605"}, {"source": "ENSG00000075461", "target": "ENSG00000108878"}, {"source": "ENSG00000075461", "target": "ENSG00000116032"}, {"source": "ENSG00000075461", "target": "ENSG00000142408"}, {"source": "ENSG00000075461", "target": "ENSG00000152578"}, {"source": "ENSG00000075461", "target": "ENSG00000153956"}, {"source": "ENSG00000075461", "target": "ENSG00000157388"}, {"source": "ENSG00000075461", "target": "ENSG00000166862"}, {"source": "ENSG00000075461", "target": "ENSG00000176884"}, {"source": "ENSG00000075461", "target": "ENSG00000183454"}, {"source": "ENSG00000075461", "target": "ENSG00000198785"}, {"source": "ENSG00000081248", "target": "ENSG00000100346"}, {"source": "ENSG00000081248", "target": "ENSG00000102001"}, {"source": "ENSG00000081248", "target": "ENSG00000105605"}, {"source": "ENSG00000081248", "target": "ENSG00000108878"}, {"source": "ENSG00000081248", "target": "ENSG00000130433"}, {"source": "ENSG00000081248", "target": "ENSG00000142408"}, {"source": "ENSG00000081248", "target": "ENSG00000148408"}, {"source": "ENSG00000081248", "target": "ENSG00000151062"}, {"source": "ENSG00000081248", "target": "ENSG00000151067"}, {"source": "ENSG00000081248", "target": "ENSG00000153956"}, {"source": "ENSG00000081248", "target": "ENSG00000157388"}, {"source": "ENSG00000081248", "target": "ENSG00000165995"}, {"source": "ENSG00000081248", "target": "ENSG00000166862"}, {"source": "ENSG00000081248", "target": "ENSG00000167535"}, {"source": "ENSG00000081248", "target": "ENSG00000182389"}, {"source": "ENSG00000081248", "target": "ENSG00000196557"}, {"source": "ENSG00000081248", "target": "ENSG00000198216"}, {"source": "ENSG00000100346", "target": "ENSG00000151067"}, {"source": "ENSG00000100346", "target": "ENSG00000157388"}, {"source": "ENSG00000100346", "target": "ENSG00000165995"}, {"source": "ENSG00000100346", "target": "ENSG00000167535"}, {"source": "ENSG00000100346", "target": "ENSG00000182389"}, {"source": "ENSG00000100346", "target": "ENSG00000196557"}, {"source": "ENSG00000102001", "target": "ENSG00000105605"}, {"source": "ENSG00000102001", "target": "ENSG00000108878"}, {"source": "ENSG00000102001", "target": "ENSG00000130433"}, {"source": "ENSG00000102001", "target": "ENSG00000142408"}, {"source": "ENSG00000102001", "target": "ENSG00000148408"}, {"source": "ENSG00000102001", "target": "ENSG00000151062"}, {"source": "ENSG00000102001", "target": "ENSG00000151067"}, {"source": "ENSG00000102001", "target": "ENSG00000153956"}, {"source": "ENSG00000102001", "target": "ENSG00000157388"}, {"source": "ENSG00000102001", "target": "ENSG00000165995"}, {"source": "ENSG00000102001", "target": "ENSG00000166862"}, {"source": "ENSG00000102001", "target": "ENSG00000167535"}, {"source": "ENSG00000102001", "target": "ENSG00000182389"}, {"source": "ENSG00000102001", "target": "ENSG00000196557"}, {"source": "ENSG00000102001", "target": "ENSG00000198216"}, {"source": "ENSG00000105464", "target": "ENSG00000152578"}, {"source": "ENSG00000105464", "target": "ENSG00000161509"}, {"source": "ENSG00000105464", "target": "ENSG00000176884"}, {"source": "ENSG00000105464", "target": "ENSG00000183454"}, {"source": "ENSG00000105605", "target": "ENSG00000108878"}, {"source": "ENSG00000105605", "target": "ENSG00000116032"}, {"source": "ENSG00000105605", "target": "ENSG00000130433"}, {"source": "ENSG00000105605", "target": "ENSG00000142408"}, {"source": "ENSG00000105605", "target": "ENSG00000148408"}, {"source": "ENSG00000105605", "target": "ENSG00000151062"}, {"source": "ENSG00000105605", "target": "ENSG00000151067"}, {"source": "ENSG00000105605", "target": "ENSG00000152578"}, {"source": "ENSG00000105605", "target": "ENSG00000153956"}, {"source": "ENSG00000105605", "target": "ENSG00000157388"}, {"source": "ENSG00000105605", "target": "ENSG00000165995"}, {"source": "ENSG00000105605", "target": "ENSG00000166862"}, {"source": "ENSG00000105605", "target": "ENSG00000167535"}, {"source": "ENSG00000105605", "target": "ENSG00000176884"}, {"source": "ENSG00000105605", "target": "ENSG00000182389"}, {"source": "ENSG00000105605", "target": "ENSG00000183454"}, {"source": "ENSG00000105605", "target": "ENSG00000196557"}, {"source": "ENSG00000105605", "target": "ENSG00000198216"}, {"source": "ENSG00000105605", "target": "ENSG00000198785"}, {"source": "ENSG00000108878", "target": "ENSG00000130433"}, {"source": "ENSG00000108878", "target": "ENSG00000142408"}, {"source": "ENSG00000108878", "target": "ENSG00000148408"}, {"source": "ENSG00000108878", "target": "ENSG00000151062"}, {"source": "ENSG00000108878", "target": "ENSG00000151067"}, {"source": "ENSG00000108878", "target": "ENSG00000153956"}, {"source": "ENSG00000108878", "target": "ENSG00000157388"}, {"source": "ENSG00000108878", "target": "ENSG00000165995"}, {"source": "ENSG00000108878", "target": "ENSG00000166862"}, {"source": "ENSG00000108878", "target": "ENSG00000167535"}, {"source": "ENSG00000108878", "target": "ENSG00000182389"}, {"source": "ENSG00000108878", "target": "ENSG00000196557"}, {"source": "ENSG00000108878", "target": "ENSG00000198216"}, {"source": "ENSG00000116032", "target": "ENSG00000142408"}, {"source": "ENSG00000116032", "target": "ENSG00000152578"}, {"source": "ENSG00000116032", "target": "ENSG00000166862"}, {"source": "ENSG00000116032", "target": "ENSG00000176884"}, {"source": "ENSG00000116032", "target": "ENSG00000183454"}, {"source": "ENSG00000116032", "target": "ENSG00000198785"}, {"source": "ENSG00000130433", "target": "ENSG00000142408"}, {"source": "ENSG00000130433", "target": "ENSG00000148408"}, {"source": "ENSG00000130433", "target": "ENSG00000151062"}, {"source": "ENSG00000130433", "target": "ENSG00000151067"}, {"source": "ENSG00000130433", "target": "ENSG00000153956"}, {"source": "ENSG00000130433", "target": "ENSG00000157388"}, {"source": "ENSG00000130433", "target": "ENSG00000165995"}, {"source": "ENSG00000130433", "target": "ENSG00000166862"}, {"source": "ENSG00000130433", "target": "ENSG00000167535"}, {"source": "ENSG00000130433", "target": "ENSG00000182389"}, {"source": "ENSG00000130433", "target": "ENSG00000196557"}, {"source": "ENSG00000130433", "target": "ENSG00000198216"}, {"source": "ENSG00000141837", "target": "ENSG00000151062"}, {"source": "ENSG00000141837", "target": "ENSG00000153956"}, {"source": "ENSG00000141837", "target": "ENSG00000165995"}, {"source": "ENSG00000141837", "target": "ENSG00000167535"}, {"source": "ENSG00000141837", "target": "ENSG00000182389"}, {"source": "ENSG00000142408", "target": "ENSG00000148408"}, {"source": "ENSG00000142408", "target": "ENSG00000151062"}, {"source": "ENSG00000142408", "target": "ENSG00000151067"}, {"source": "ENSG00000142408", "target": "ENSG00000152578"}, {"source": "ENSG00000142408", "target": "ENSG00000153956"}, {"source": "ENSG00000142408", "target": "ENSG00000157388"}, {"source": "ENSG00000142408", "target": "ENSG00000165995"}, {"source": "ENSG00000142408", "target": "ENSG00000166862"}, {"source": "ENSG00000142408", "target": "ENSG00000167535"}, {"source": "ENSG00000142408", "target": "ENSG00000176884"}, {"source": "ENSG00000142408", "target": "ENSG00000182389"}, {"source": "ENSG00000142408", "target": "ENSG00000183454"}, {"source": "ENSG00000142408", "target": "ENSG00000196557"}, {"source": "ENSG00000142408", "target": "ENSG00000198216"}, {"source": "ENSG00000142408", "target": "ENSG00000198785"}, {"source": "ENSG00000148408", "target": "ENSG00000151062"}, {"source": "ENSG00000148408", "target": "ENSG00000151067"}, {"source": "ENSG00000148408", "target": "ENSG00000153956"}, {"source": "ENSG00000148408", "target": "ENSG00000157388"}, {"source": "ENSG00000148408", "target": "ENSG00000165995"}, {"source": "ENSG00000148408", "target": "ENSG00000166862"}, {"source": "ENSG00000148408", "target": "ENSG00000167535"}, {"source": "ENSG00000148408", "target": "ENSG00000182389"}, {"source": "ENSG00000148408", "target": "ENSG00000196557"}, {"source": "ENSG00000148408", "target": "ENSG00000198216"}, {"source": "ENSG00000151062", "target": "ENSG00000151067"}, {"source": "ENSG00000151062", "target": "ENSG00000153956"}, {"source": "ENSG00000151062", "target": "ENSG00000157388"}, {"source": "ENSG00000151062", "target": "ENSG00000165995"}, {"source": "ENSG00000151062", "target": "ENSG00000166862"}, {"source": "ENSG00000151062", "target": "ENSG00000167535"}, {"source": "ENSG00000151062", "target": "ENSG00000182389"}, {"source": "ENSG00000151062", "target": "ENSG00000196557"}, {"source": "ENSG00000151062", "target": "ENSG00000198216"}, {"source": "ENSG00000151067", "target": "ENSG00000153956"}, {"source": "ENSG00000151067", "target": "ENSG00000157388"}, {"source": "ENSG00000151067", "target": "ENSG00000165995"}, {"source": "ENSG00000151067", "target": "ENSG00000166862"}, {"source": "ENSG00000151067", "target": "ENSG00000167535"}, {"source": "ENSG00000151067", "target": "ENSG00000182389"}, {"source": "ENSG00000151067", "target": "ENSG00000196557"}, {"source": "ENSG00000151067", "target": "ENSG00000198216"}, {"source": "ENSG00000152578", "target": "ENSG00000166862"}, {"source": "ENSG00000152578", "target": "ENSG00000176884"}, {"source": "ENSG00000152578", "target": "ENSG00000183454"}, {"source": "ENSG00000152578", "target": "ENSG00000198785"}, {"source": "ENSG00000153956", "target": "ENSG00000157388"}, {"source": "ENSG00000153956", "target": "ENSG00000165995"}, {"source": "ENSG00000153956", "target": "ENSG00000166862"}, {"source": "ENSG00000153956", "target": "ENSG00000167535"}, {"source": "ENSG00000153956", "target": "ENSG00000182389"}, {"source": "ENSG00000153956", "target": "ENSG00000196557"}, {"source": "ENSG00000153956", "target": "ENSG00000198216"}, {"source": "ENSG00000157388", "target": "ENSG00000165995"}, {"source": "ENSG00000157388", "target": "ENSG00000166862"}, {"source": "ENSG00000157388", "target": "ENSG00000167535"}, {"source": "ENSG00000157388", "target": "ENSG00000182389"}, {"source": "ENSG00000157388", "target": "ENSG00000196557"}, {"source": "ENSG00000157388", "target": "ENSG00000198216"}, {"source": "ENSG00000161509", "target": "ENSG00000176884"}, {"source": "ENSG00000161509", "target": "ENSG00000183454"}, {"source": "ENSG00000165995", "target": "ENSG00000166862"}, {"source": "ENSG00000165995", "target": "ENSG00000167535"}, {"source": "ENSG00000165995", "target": "ENSG00000182389"}, {"source": "ENSG00000165995", "target": "ENSG00000196557"}, {"source": "ENSG00000165995", "target": "ENSG00000198216"}, {"source": "ENSG00000166862", "target": "ENSG00000167535"}, {"source": "ENSG00000166862", "target": "ENSG00000176884"}, {"source": "ENSG00000166862", "target": "ENSG00000182389"}, {"source": "ENSG00000166862", "target": "ENSG00000183454"}, {"source": "ENSG00000166862", "target": "ENSG00000196557"}, {"source": "ENSG00000166862", "target": "ENSG00000198216"}, {"source": "ENSG00000166862", "target": "ENSG00000198785"}, {"source": "ENSG00000167535", "target": "ENSG00000182389"}, {"source": "ENSG00000167535", "target": "ENSG00000196557"}, {"source": "ENSG00000167535", "target": "ENSG00000198216"}, {"source": "ENSG00000176884", "target": "ENSG00000183454"}, {"source": "ENSG00000176884", "target": "ENSG00000198785"}, {"source": "ENSG00000182389", "target": "ENSG00000196557"}, {"source": "ENSG00000182389", "target": "ENSG00000198216"}, {"source": "ENSG00000183454", "target": "ENSG00000198785"}, {"source": "ENSG00000196557", "target": "ENSG00000198216"}], "drugs": [{"indications": [{"efo_term": "FIBROMYALGIA", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "NEUROPATHIC PAIN", "stage": 4}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 3}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "GENICULATE HERPES ZOSTER", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "CHRONIC PANCREATITIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "ABNORMALITY OF REFRACTION", "stage": 1}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 1}, {"efo_term": "COUGH", "stage": 1}, {"efo_term": "PREGNANCY", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 0}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 0}], "max_phase": 4, "name": "PREGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1059", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1G", "CACNA2D2", "CACNB1", "CACNG5", "CACNG4", "CACNA1S", "CACNA1I", "CACNA1F", "CACNG7", "CACNG1", "CACNG6", "CACNA1A", "CACNG8", "CACNA1B", "CACNA2D4", "CACNA1C", "CACNA2D1", "CACNA1D", "CACNB2", "CACNG2", "CACNB3", "CACNB4", "CACNA1H", "CACNA1E"], "type": "Small molecule", "diseases": ["FIBROMYALGIA", "NEUROPATHY", "PAIN", "PARTIAL EPILEPSY", "RESTLESS LEGS SYNDROME", "SEIZURES", "ABNORMALITY OF REFRACTION", "ALCOHOL DEPENDENCE", "EPILEPSY", "GENERALIZED TONIC-CLONIC SEIZURES", "IRRITABLE BOWEL SYNDROME", "NEUROPATHIC PAIN", "LUMBAR DISC DEGENERATION", "CHRONIC PANCREATITIS", "NICOTINE DEPENDENCE", "BONE FRACTURE", "DRY EYE SYNDROME", "SQUAMOUS CELL CARCINOMA", "CIRRHOSIS OF LIVER", "COUGH", "GENICULATE HERPES ZOSTER", "DIABETIC NEUROPATHY", "OVERACTIVE BLADDER", "PREGNANCY", "MARIJUANA DEPENDENCE", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "LUMBAR DISC DEGENERATION", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 3}, {"efo_term": "VOMITING", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SPONTANEOUS ABORTION", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}, {"efo_term": "PRURITUS", "stage": 1}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}, {"efo_term": "PSYCHOSIS", "stage": 1}], "max_phase": 4, "name": "GABAPENTIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL940", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1G", "CACNA2D2", "CACNB1", "CACNG5", "CACNG4", "CACNA1S", "CACNA1I", "CACNA1F", "CACNG7", "CACNG1", "CACNG6", "CACNA1A", "CACNG8", "CACNA1B", "CACNA2D4", "CACNA1C", "CACNA2D1", "CACNA1D", "CACNB2", "CACNG2", "CACNB3", "CACNB4", "CACNA1H", "CACNA1E"], "type": "Small molecule", "diseases": ["INSOMNIA", "PAIN", "PRURITUS", "SCOLIOSIS", "SICKLE CELL ANEMIA", "TINNITUS", "EPILEPSY", "PROSTATE CARCINOMA", "ALCOHOL DEPENDENCE", "CARPAL TUNNEL SYNDROME", "NEUROPATHIC PAIN", "PREMATURE BIRTH", "FIBROMYALGIA", "LUMBAR DISC DEGENERATION", "NEOPLASM", "PARTIAL EPILEPSY", "CIRRHOSIS OF LIVER", "NICOTINE DEPENDENCE", "SPONTANEOUS ABORTION", "DRUG DEPENDENCE", "OPIOID DEPENDENCE", "VOMITING", "PSYCHOSIS", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "PANIC DISORDER", "stage": 3}, {"efo_term": "ALCOHOL WITHDRAWAL", "stage": 3}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "MOVEMENT DISORDER", "stage": 3}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 1}, {"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "LEVETIRACETAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1286", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "COGNITIVE IMPAIRMENT", "ALZHEIMERS DISEASE", "ESSENTIAL TREMOR", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "ALCOHOL WITHDRAWAL", "SUBARACHNOID HEMORRHAGE", "ALCOHOL DEPENDENCE", "MOVEMENT DISORDER", "PARTIAL EPILEPSY", "STROKE", "GLIOBLASTOMA MULTIFORME"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "PRINZMETAL'S ANGINA", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "STROKE", "stage": 4}, {"efo_term": "PROTEINURIA", "stage": 3}], "max_phase": 4, "name": "AMLODIPINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200402", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "CORONARY ARTERY DISEASE", "PROTEINURIA", "ANGINA PECTORIS", "PRINZMETAL'S ANGINA", "MYOCARDIAL INFARCTION", "STROKE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "POSTENCEPHALITIC PARKINSON DISEASE", "stage": 4}, {"efo_term": "INFECTION", "stage": 4}, {"efo_term": "SECONDARY PARKINSON DISEASE", "stage": 4}, {"efo_term": "CEREBRAL ATHEROSCLEROSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "INJURY", "stage": 2}], "max_phase": 4, "name": "AMANTADINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1569", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "CANCER", "INJURY", "INFLUENZA INFECTION", "POSTENCEPHALITIC PARKINSON DISEASE", "INFECTION", "SECONDARY PARKINSON DISEASE", "CEREBRAL ATHEROSCLEROSIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}, {"efo_term": "TORTICOLLIS", "stage": 1}], "max_phase": 4, "name": "PERAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1214124", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARKINSON'S DISEASE", "SEIZURES", "TORTICOLLIS", "NEUROPATHIC PAIN", "MIGRAINE DISORDER", "ESSENTIAL TREMOR", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "BRAIN ANEURYSM", "stage": 1}], "max_phase": 4, "name": "NIMODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1428", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["INFERTILITY", "CARDIOVASCULAR DISEASE", "BRAIN ANEURYSM", "STROKE", "SUBARACHNOID HEMORRHAGE"]}, {"indications": [{"efo_term": "RESTLESS LEGS SYNDROME", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 4, "name": "GABAPENTIN ENACARBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1628502", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1G", "CACNA2D2", "CACNB1", "CACNG5", "CACNG4", "CACNA1S", "CACNA1I", "CACNA1F", "CACNG7", "CACNG1", "CACNG6", "CACNA1A", "CACNG8", "CACNA1B", "CACNA2D4", "CACNA1C", "CACNA2D1", "CACNA1D", "CACNB2", "CACNG2", "CACNB3", "CACNB4", "CACNA1H", "CACNA1E"], "type": "Small molecule", "diseases": ["RESTLESS LEGS SYNDROME", "EPILEPSY", "ALCOHOL DEPENDENCE", "MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "ANAL FISSURE", "stage": 2}], "max_phase": 4, "name": "NIFEDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL193", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["ANAL FISSURE", "PREMATURE BIRTH", "KIDNEY STONE", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "OPIOID DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ISRADIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1648", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "BIPOLAR DISORDER", "CARDIOVASCULAR DISEASE", "OPIOID DEPENDENCE"]}, {"indications": [{"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "ANAL FISSURE", "stage": 3}, {"efo_term": "CONSTIPATION", "stage": 1}, {"efo_term": "SKIN DISEASE", "stage": 1}], "max_phase": 4, "name": "DILTIAZEM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1697", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["CONSTIPATION", "ANAL FISSURE", "SKIN DISEASE", "ANGINA PECTORIS"]}, {"indications": [{"efo_term": "SUICIDAL IDEATION", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "KETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1714", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SUICIDAL IDEATION", "COCAINE DEPENDENCE", "INJURY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "REFLEX SYMPATHETIC DYSTROPHY", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 1}], "max_phase": 4, "name": "ETHOSUXIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL696", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1G", "CACNA1I", "CACNA1H"], "type": "Small molecule", "diseases": ["EPILEPSY", "MIGRAINE DISORDER", "REFLEX SYMPATHETIC DYSTROPHY"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "SCOLIOSIS", "stage": 2}], "max_phase": 4, "name": "CLEVIDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237132", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "SCOLIOSIS", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "TINNITUS", "stage": 2}], "max_phase": 2, "name": "Selurampanel", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545042", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "SEIZURES", "TINNITUS"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 1}], "max_phase": 3, "name": "IMAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103836", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1G", "CACNA2D2", "CACNB1", "CACNG5", "CACNG4", "CACNA1S", "CACNA1I", "CACNA1F", "CACNG7", "CACNG1", "CACNG6", "CACNA1A", "CACNG8", "CACNA1B", "CACNA2D4", "CACNA1C", "CACNA2D1", "CACNA1D", "CACNB2", "CACNG2", "CACNB3", "CACNB4", "CACNA1H", "CACNA1E"], "type": "Small molecule", "diseases": ["ANXIETY", "RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "INTRACEREBRAL HEMORRHAGE", "stage": 3}], "max_phase": 4, "name": "NICARDIPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200326", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "INTRACEREBRAL HEMORRHAGE"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL395091", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["LIVER DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}], "max_phase": 4, "name": "MEMANTINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1699", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["GAMBLING BEHAVIOUR", "CANCER"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Glutamate [NMDA] receptor antagonist", "Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["GRIN2D", "GRIN3B", "CACNA1B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 3, "name": "RAPASTINEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544917", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Protein", "diseases": ["OBSESSIVE-COMPULSIVE DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "NRX-1074", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545230", "mechanisms": ["Glutamate [NMDA] receptor partial agonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 2, "name": "AV-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545351", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "ZICONOTIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1795072", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Protein", "diseases": ["FEVER", "PAIN"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "FARAMPATOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1276138", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "MK-8777", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707401", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "DIABETIC RETINOPATHY", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "DEXTROMETHORPHAN HYDROBROMIDE MONOHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256818", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["DIABETIC RETINOPATHY", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ATAGABALIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL593430", "mechanisms": ["Voltage-gated calcium channel modulator"], "genes": ["CACNG3", "CACNA1G", "CACNA2D2", "CACNB1", "CACNG5", "CACNG4", "CACNA1S", "CACNA1I", "CACNA1F", "CACNG7", "CACNG1", "CACNG6", "CACNA1A", "CACNG8", "CACNA1B", "CACNA2D4", "CACNA1C", "CACNA2D1", "CACNA1D", "CACNB2", "CACNG2", "CACNB3", "CACNB4", "CACNA1H", "CACNA1E"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "TRIMETHADIONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL695", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1G", "CACNA1I", "CACNA1H"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "METHSUXIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL697", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1G", "CACNA1I", "CACNA1H"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PHENSUXIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL797", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1G", "CACNA1I", "CACNA1H"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PARAMETHADIONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1100", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1G", "CACNA1I", "CACNA1H"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "FELODIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1480", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "NISOLDIPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1726", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "FELBAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "GW468816", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1207366", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "TINNITUS", "stage": 3}], "max_phase": 3, "name": "NERAMEXANE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106798", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["TINNITUS"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "LANICEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107647", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "PAIN", "stage": 1}], "max_phase": 4, "name": "ESKETAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364609", "mechanisms": ["Glutamate [NMDA] receptor negative allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Indantadol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707400", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "CNV2197944", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545172", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": ["DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 2, "name": "TEZAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14935", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "MIBAMPATOR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1277001", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "PF-04958242", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707379", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 2, "name": "Radiprodil", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL182066", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "CERC-301", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068839", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}], "max_phase": 4, "name": "DEXTROMETHORPHAN POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201461", "mechanisms": ["Glutamate [NMDA] receptor subunit epsilon 1 antagonist"], "genes": ["GRIN2A"], "type": "Small molecule", "diseases": ["AUTISM SPECTRUM DISORDER"]}, {"indications": [], "max_phase": 4, "name": "BEPRIDIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200382", "mechanisms": ["Voltage-gated calcium channel blocker"], "genes": ["CACNG3", "CACNA1G", "CACNA2D2", "CACNB1", "CACNG5", "CACNG4", "CACNA1S", "CACNA1I", "CACNA1F", "CACNG7", "CACNG1", "CACNG6", "CACNA1A", "CACNG8", "CACNA1B", "CACNA2D4", "CACNA1C", "CACNA2D1", "CACNA1D", "CACNB2", "CACNG2", "CACNB3", "CACNB4", "CACNA1H", "CACNA1E"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MIBEFRADIL DIHYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1534525", "mechanisms": ["Voltage-gated T-type calcium channel blocker"], "genes": ["CACNA1G", "CACNA1I", "CACNA1H"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "MIROGABALIN BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545257", "mechanisms": ["Voltage-gated calcium channel alpha2/delta subunit 2 modulator", "Voltage-gated calcium channel alpha2/delta subunit 1 modulator"], "genes": ["CACNA2D2", "CACNA2D1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Voltage-gated L-type calcium channel blocker", "Voltage-gated P/Q-type calcium channel alpha-1A subunit blocker", "Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1A", "CACNA1B", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "VERAPAMIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1280", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DILTIAZEM MALATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200805", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMLODIPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200984", "mechanisms": ["Voltage-gated L-type calcium channel blocker"], "genes": ["CACNA1S", "CACNA1F", "CACNA1C", "CACNA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "CNS-5161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL41306", "mechanisms": ["Glutamate [NMDA] receptor blocker"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NEBOGLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255840", "mechanisms": ["Glutamate [NMDA] receptor positive allosteric modulator"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACAMPROSATE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068724", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DELUCEMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2110814", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD8108", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707355", "mechanisms": ["Glutamate [NMDA] receptor antagonist"], "genes": ["GRIN2D", "GRIN3B", "GRIN2C", "GRIN1", "GRIN2A", "GRIN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Z160", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL604710", "mechanisms": ["Voltage-gated N-type calcium channel alpha-1B subunit blocker"], "genes": ["CACNA1B"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ZONAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL119625", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA4"], "type": "Protein", "diseases": []}, {"indications": [], "max_phase": 0, "name": "DASOLAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103869", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "BECAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107735", "mechanisms": ["Glutamate receptor ionotropic AMPA antagonist"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CX1739", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707399", "mechanisms": ["Glutamate receptor ionotropic AMPA positive allosteric modulator"], "genes": ["GRIA4"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "TRAXOPRODIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL17350", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "EVT-101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545349", "mechanisms": ["Glutamate NMDA receptor; GRIN1/GRIN2B antagonist"], "genes": ["GRIN1"], "type": "Small molecule", "diseases": []}], "heat": 0.97660890625, "nodes": [{"assoc": 1.0, "id": "ENSG00000006116", "label": "CACNG3"}, {"assoc": 1.0, "id": "ENSG00000006283", "label": "CACNA1G"}, {"assoc": 1.0, "id": "ENSG00000007402", "label": "CACNA2D2"}, {"assoc": 1.0, "id": "ENSG00000067191", "label": "CACNB1"}, {"assoc": 1.0, "id": "ENSG00000075429", "label": "CACNG5"}, {"assoc": 1.0, "id": "ENSG00000075461", "label": "CACNG4"}, {"assoc": 1.0, "id": "ENSG00000081248", "label": "CACNA1S"}, {"assoc": 1.0, "id": "ENSG00000100346", "label": "CACNA1I"}, {"assoc": 1.0, "id": "ENSG00000102001", "label": "CACNA1F"}, {"assoc": 1.0, "id": "ENSG00000105464", "label": "GRIN2D"}, {"assoc": 1.0, "id": "ENSG00000105605", "label": "CACNG7"}, {"assoc": 1.0, "id": "ENSG00000108878", "label": "CACNG1"}, {"assoc": 1.0, "id": "ENSG00000116032", "label": "GRIN3B"}, {"assoc": 1.0, "id": "ENSG00000130433", "label": "CACNG6"}, {"assoc": 1.0, "id": "ENSG00000141837", "label": "CACNA1A"}, {"assoc": 1.0, "id": "ENSG00000142408", "label": "CACNG8"}, {"assoc": 1.0, "id": "ENSG00000148408", "label": "CACNA1B"}, {"assoc": 1.0, "id": "ENSG00000151062", "label": "CACNA2D4"}, {"assoc": 1.0, "id": "ENSG00000151067", "label": "CACNA1C"}, {"assoc": 0.251485, "id": "ENSG00000152578", "label": "GRIA4"}, {"assoc": 1.0, "id": "ENSG00000153956", "label": "CACNA2D1"}, {"assoc": 1.0, "id": "ENSG00000157388", "label": "CACNA1D"}, {"assoc": 1.0, "id": "ENSG00000161509", "label": "GRIN2C"}, {"assoc": 1.0, "id": "ENSG00000165995", "label": "CACNB2"}, {"assoc": 1.0, "id": "ENSG00000166862", "label": "CACNG2"}, {"assoc": 1.0, "id": "ENSG00000167535", "label": "CACNB3"}, {"assoc": 1.0, "id": "ENSG00000176884", "label": "GRIN1"}, {"assoc": 1.0, "id": "ENSG00000182389", "label": "CACNB4"}, {"assoc": 1.0, "id": "ENSG00000183454", "label": "GRIN2A"}, {"assoc": 1.0, "id": "ENSG00000196557", "label": "CACNA1H"}, {"assoc": 1.0, "id": "ENSG00000198216", "label": "CACNA1E"}, {"assoc": 1.0, "id": "ENSG00000198785", "label": "GRIN3A"}], "size": 32}, {"diseases": ["ALZHEIMERS DISEASE", "ACNE", "PERIODONTITIS", "BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PAIN", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS", "NON-SMALL CELL LUNG CARCINOMA", "CYSTIC FIBROSIS", "MELANOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "MULTIPLE MYELOMA", "CUTANEOUS MELANOMA", "MANTLE CELL LYMPHOMA", "LYMPHOMA", "NEOPLASM", "SMALL CELL LUNG CARCINOMA", "DISORDER OF LIPID METABOLISM", "HYPERCHOLESTEROLEMIA", "FAMILIAL HYPERCHOLESTEROLEMIA", "ACUTE CORONARY SYNDROME", "CORONARY ARTERY DISEASE", "CARDIOVASCULAR DISEASE", "HYPERLIPIDEMIA", "HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA"], "links": [{"source": "ENSG00000014216", "target": "ENSG00000126247"}, {"source": "ENSG00000014216", "target": "ENSG00000143801"}, {"source": "ENSG00000014216", "target": "ENSG00000153113"}, {"source": "ENSG00000014216", "target": "ENSG00000176749"}, {"source": "ENSG00000080815", "target": "ENSG00000115041"}, {"source": "ENSG00000080815", "target": "ENSG00000130203"}, {"source": "ENSG00000080815", "target": "ENSG00000138613"}, {"source": "ENSG00000080815", "target": "ENSG00000143801"}, {"source": "ENSG00000080815", "target": "ENSG00000162736"}, {"source": "ENSG00000080815", "target": "ENSG00000164885"}, {"source": "ENSG00000080815", "target": "ENSG00000169862"}, {"source": "ENSG00000080815", "target": "ENSG00000186318"}, {"source": "ENSG00000080815", "target": "ENSG00000205155"}, {"source": "ENSG00000100979", "target": "ENSG00000130203"}, {"source": "ENSG00000113070", "target": "ENSG00000137673"}, {"source": "ENSG00000113070", "target": "ENSG00000137845"}, {"source": "ENSG00000115041", "target": "ENSG00000143801"}, {"source": "ENSG00000118113", "target": "ENSG00000137673"}, {"source": "ENSG00000118113", "target": "ENSG00000196611"}, {"source": "ENSG00000126247", "target": "ENSG00000153113"}, {"source": "ENSG00000126247", "target": "ENSG00000162909"}, {"source": "ENSG00000130203", "target": "ENSG00000137642"}, {"source": "ENSG00000130203", "target": "ENSG00000234906"}, {"source": "ENSG00000132688", "target": "ENSG00000164885"}, {"source": "ENSG00000132688", "target": "ENSG00000176749"}, {"source": "ENSG00000137673", "target": "ENSG00000196611"}, {"source": "ENSG00000137845", "target": "ENSG00000138613"}, {"source": "ENSG00000137845", "target": "ENSG00000143801"}, {"source": "ENSG00000137845", "target": "ENSG00000162736"}, {"source": "ENSG00000137845", "target": "ENSG00000205155"}, {"source": "ENSG00000138613", "target": "ENSG00000143801"}, {"source": "ENSG00000138613", "target": "ENSG00000162736"}, {"source": "ENSG00000138613", "target": "ENSG00000205155"}, {"source": "ENSG00000143801", "target": "ENSG00000162736"}, {"source": "ENSG00000143801", "target": "ENSG00000205155"}, {"source": "ENSG00000153113", "target": "ENSG00000162909"}, {"source": "ENSG00000162736", "target": "ENSG00000185896"}, {"source": "ENSG00000162736", "target": "ENSG00000186318"}, {"source": "ENSG00000162736", "target": "ENSG00000205155"}, {"source": "ENSG00000162909", "target": "ENSG00000176749"}, {"source": "ENSG00000164885", "target": "ENSG00000176749"}, {"source": "ENSG00000169174", "target": "ENSG00000186318"}], "drugs": [{"indications": [{"efo_term": "PERIODONTITIS", "stage": 3}, {"efo_term": "URETHRITIS", "stage": 3}, {"efo_term": "HEMORRHAGE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PLEURAL EFFUSION", "stage": 3}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 3}, {"efo_term": "BLEPHARITIS", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "NEOPLASM OF MATURE B-CELLS", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "ABDOMINAL AORTIC ANEURYSM", "stage": 2}, {"efo_term": "MARFAN SYNDROME", "stage": 2}, {"efo_term": "PRIMARY SYSTEMIC AMYLOIDOSIS", "stage": 2}, {"efo_term": "DRY EYE SYNDROME", "stage": 2}, {"efo_term": "SEPTICEMIC PLAGUE", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "PANCREATIC CARCINOMA", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "DIABETIC FOOT", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "TUBERCULOSIS", "stage": 2}], "max_phase": 4, "name": "DOXYCYCLINE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200699", "mechanisms": ["Matrix metalloproteinase 8 inhibitor", "Matrix metalloproteinase 7 inhibitor", "Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP8", "MMP7", "MMP1"], "type": "Small molecule", "diseases": ["BLEPHARITIS", "COLORECTAL ADENOCARCINOMA", "PERIODONTITIS", "ACNE", "DIABETIC RETINOPATHY", "URETHRITIS", "HEMORRHAGE", "NEOPLASM OF MATURE B-CELLS", "ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "PAIN", "PLEURAL EFFUSION", "ABDOMINAL AORTIC ANEURYSM", "MARFAN SYNDROME", "PRIMARY SYSTEMIC AMYLOIDOSIS", "DRY EYE SYNDROME", "SEPTICEMIC PLAGUE", "POLYCYSTIC OVARY SYNDROME", "MYOCARDIAL INFARCTION", "PANCREATIC CARCINOMA", "SEIZURES", "DIABETIC FOOT", "AGE-RELATED MACULAR DEGENERATION", "TUBERCULOSIS"]}, {"indications": [{"efo_term": "CORONARY ARTERY DISEASE", "stage": 4}, {"efo_term": "FAMILIAL HYPERCHOLESTEROLEMIA", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA", "stage": 4}, {"efo_term": "HYPERLIPIDEMIA", "stage": 3}, {"efo_term": "HYPERCHOLESTEROLEMIA", "stage": 3}, {"efo_term": "DISORDER OF LIPID METABOLISM", "stage": 3}], "max_phase": 4, "name": "EVOLOCUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364655", "mechanisms": ["Subtilisin/kexin type 9 inhibitor"], "genes": ["PCSK9"], "type": "Antibody", "diseases": ["CORONARY ARTERY DISEASE", "FAMILIAL HYPERCHOLESTEROLEMIA", "CARDIOVASCULAR DISEASE", "HYPERLIPIDEMIA", "HYPERCHOLESTEROLEMIA", "HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA", "DISORDER OF LIPID METABOLISM"]}, {"indications": [{"efo_term": "FAMILIAL HYPERCHOLESTEROLEMIA", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "DISORDER OF LIPID METABOLISM", "stage": 3}, {"efo_term": "HYPERCHOLESTEROLEMIA", "stage": 3}, {"efo_term": "ACUTE CORONARY SYNDROME", "stage": 3}], "max_phase": 4, "name": "Alirocumab", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109540", "mechanisms": ["Subtilisin/kexin type 9 inhibitor"], "genes": ["PCSK9"], "type": "Antibody", "diseases": ["DISORDER OF LIPID METABOLISM", "HYPERCHOLESTEROLEMIA", "FAMILIAL HYPERCHOLESTEROLEMIA", "ACUTE CORONARY SYNDROME", "CORONARY ARTERY DISEASE", "CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 3}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "MULTIPLE MYELOMA", "stage": 2}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}], "max_phase": 3, "name": "DINACICLIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103840", "mechanisms": ["Cyclin-dependent kinase 5 inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": ["MELANOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "MULTIPLE MYELOMA", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "MANTLE CELL LYMPHOMA", "stage": 2}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 2}, {"efo_term": "LYMPHOMA", "stage": 1}], "max_phase": 2, "name": "AT-7519", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL445813", "mechanisms": ["Cyclin-dependent kinase inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": ["MANTLE CELL LYMPHOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "LYMPHOMA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 3}, {"efo_term": "HYPERLIPIDEMIA", "stage": 3}, {"efo_term": "HYPERCHOLESTEROLEMIA", "stage": 2}], "max_phase": 3, "name": "BOCOCIZUMAB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137349", "mechanisms": ["Subtilisin/kexin type 9 inhibitor"], "genes": ["PCSK9"], "type": "Antibody", "diseases": ["HYPERCHOLESTEROLEMIA", "CARDIOVASCULAR DISEASE", "HYPERLIPIDEMIA"]}, {"indications": [{"efo_term": "ACNE", "stage": 4}, {"efo_term": "PERIODONTITIS", "stage": 3}], "max_phase": 4, "name": "DOXYCYCLINE HYCLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200567", "mechanisms": ["Matrix metalloproteinase 8 inhibitor", "Matrix metalloproteinase 7 inhibitor", "Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP8", "MMP7", "MMP1"], "type": "Small molecule", "diseases": ["ACNE", "PERIODONTITIS"]}, {"indications": [{"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "CYSTIC FIBROSIS", "stage": 2}], "max_phase": 2, "name": "SELICICLIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14762", "mechanisms": ["Cyclin-dependent kinase 5 inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": ["NON-SMALL CELL LUNG CARCINOMA", "CYSTIC FIBROSIS"]}, {"indications": [{"efo_term": "SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}], "max_phase": 2, "name": "Roniciclib", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544942", "mechanisms": ["Cyclin-dependent kinase inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": ["SMALL CELL LUNG CARCINOMA", "NEOPLASM"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}], "max_phase": 3, "name": "TARENFLURBIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL190083", "mechanisms": ["Gamma-secretase modulator"], "genes": ["PSEN1", "APH1B", "PSEN2", "NCSTN", "PSENEN"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}], "max_phase": 3, "name": "SEMAGACESTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL520733", "mechanisms": ["Gamma-secretase inhibitor"], "genes": ["PSEN1", "APH1B", "PSEN2", "NCSTN", "PSENEN"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 1, "name": "BEGACESTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL463981", "mechanisms": ["Gamma-secretase inhibitor"], "genes": ["PSEN1", "APH1B", "PSEN2", "NCSTN", "PSENEN"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "AVAGACESTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1090771", "mechanisms": ["Gamma-secretase inhibitor"], "genes": ["PSEN1", "APH1B", "PSEN2", "NCSTN", "PSENEN"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 1, "name": "PHA-793887", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1230607", "mechanisms": ["Cyclin-dependent kinase inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}], "max_phase": 0, "name": "ELENBECESTAT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3833309", "mechanisms": ["Beta-secretase 1 inhibitor"], "genes": ["BACE1"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [], "max_phase": 4, "name": "DOXYCYCLINE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2364574", "mechanisms": ["Matrix metalloproteinase 8 inhibitor", "Matrix metalloproteinase 7 inhibitor", "Matrix metalloproteinase-1 inhibitor"], "genes": ["MMP8", "MMP7", "MMP1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "RGB-286638", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545083", "mechanisms": ["Cyclin-dependent kinase 5 inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD-5438", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL488436", "mechanisms": ["Cyclin-dependent kinase inhibitor"], "genes": ["CDK5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RG-7652", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2109539", "mechanisms": ["Subtilisin/kexin type 9 inhibitor"], "genes": ["PCSK9"], "type": "Antibody", "diseases": []}], "heat": 0.7175325003277077, "nodes": [{"assoc": 1.0, "id": "ENSG00000014216", "label": "CAPN1"}, {"assoc": 1.0, "id": "ENSG00000080815", "label": "PSEN1"}, {"assoc": 0.0581839984354, "id": "ENSG00000100979", "label": "PLTP"}, {"assoc": 0.418091532517, "id": "ENSG00000113070", "label": "HBEGF"}, {"assoc": 0.0890131446995, "id": "ENSG00000115041", "label": "KCNIP3"}, {"assoc": 0.875, "id": "ENSG00000118113", "label": "MMP8"}, {"assoc": 1.0, "id": "ENSG00000126247", "label": "CAPNS1"}, {"assoc": 1.0, "id": "ENSG00000130203", "label": "APOE"}, {"assoc": 0.0480612222222, "id": "ENSG00000132688", "label": "NES"}, {"assoc": 1.0, "id": "ENSG00000137642", "label": "SORL1"}, {"assoc": 0.88009725, "id": "ENSG00000137673", "label": "MMP7"}, {"assoc": 0.891103138096, "id": "ENSG00000137845", "label": "ADAM10"}, {"assoc": 1.0, "id": "ENSG00000138613", "label": "APH1B"}, {"assoc": 1.0, "id": "ENSG00000143801", "label": "PSEN2"}, {"assoc": 1.0, "id": "ENSG00000153113", "label": "CAST"}, {"assoc": 1.0, "id": "ENSG00000162736", "label": "NCSTN"}, {"assoc": 1.0, "id": "ENSG00000162909", "label": "CAPN2"}, {"assoc": 1.0, "id": "ENSG00000164885", "label": "CDK5"}, {"assoc": 0.0969907942764, "id": "ENSG00000169174", "label": "PCSK9"}, {"assoc": 0.178044298317, "id": "ENSG00000169862", "label": "CTNND2"}, {"assoc": 1.0, "id": "ENSG00000176749", "label": "CDK5R1"}, {"assoc": 0.2267477031, "id": "ENSG00000185896", "label": "LAMP1"}, {"assoc": 0.950065642095, "id": "ENSG00000186318", "label": "BACE1"}, {"assoc": 0.8839945, "id": "ENSG00000196611", "label": "MMP1"}, {"assoc": 1.0, "id": "ENSG00000205155", "label": "PSENEN"}, {"assoc": 0.0604517847619, "id": "ENSG00000234906", "label": "APOC2"}], "size": 26}, {"diseases": ["INSOMNIA", "OBSESSIVE-COMPULSIVE DISORDER", "EPILEPSY", "SEIZURES", "ANXIETY", "PAIN", "HEART DISEASE", "INJURY", "DRUG DEPENDENCE", "NEUROPATHIC PAIN", "MARIJUANA DEPENDENCE", "LEUKEMIA", "MIGRAINE DISORDER", "MORBID OBESITY", "RESPIRATORY INSUFFICIENCY", "HYPERTENSION", "SUBARACHNOID HEMORRHAGE", "HYPOTENSION", "CORONARY ARTERY DISEASE", "PREMATURE BIRTH", "OBSTRUCTIVE SLEEP APNEA", "UNIPOLAR DEPRESSION", "INFLAMMATION", "DEMENTIA", "ANXIETY DISORDER", "ALZHEIMERS DISEASE", "ALCOHOL DEPENDENCE", "COCAINE DEPENDENCE", "PANIC DISORDER", "POST-TRAUMATIC STRESS DISORDER", "STROKE", "DRAVET SYNDROME", "LENNOX-GASTAUT SYNDROME", "OPIOID DEPENDENCE", "INGUINAL HERNIA", "FEVER", "CANCER", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "ACUTE RESPIRATORY DISTRESS SYNDROME", "ACUTE KIDNEY INJURY", "POST-OPERATIVE SIGN OR SYMPTOM", "COLORECTAL ADENOCARCINOMA", "AUTISM SPECTRUM DISORDER"], "links": [{"source": "ENSG00000022355", "target": "ENSG00000109158"}, {"source": "ENSG00000022355", "target": "ENSG00000113327"}, {"source": "ENSG00000022355", "target": "ENSG00000115896"}, {"source": "ENSG00000022355", "target": "ENSG00000145863"}, {"source": "ENSG00000022355", "target": "ENSG00000145864"}, {"source": "ENSG00000022355", "target": "ENSG00000151834"}, {"source": "ENSG00000022355", "target": "ENSG00000163288"}, {"source": "ENSG00000022355", "target": "ENSG00000166206"}, {"source": "ENSG00000022355", "target": "ENSG00000182256"}, {"source": "ENSG00000022355", "target": "ENSG00000186297"}, {"source": "ENSG00000094755", "target": "ENSG00000115896"}, {"source": "ENSG00000102287", "target": "ENSG00000115896"}, {"source": "ENSG00000109158", "target": "ENSG00000113327"}, {"source": "ENSG00000109158", "target": "ENSG00000115896"}, {"source": "ENSG00000109158", "target": "ENSG00000145863"}, {"source": "ENSG00000109158", "target": "ENSG00000145864"}, {"source": "ENSG00000109158", "target": "ENSG00000151834"}, {"source": "ENSG00000109158", "target": "ENSG00000163288"}, {"source": "ENSG00000109158", "target": "ENSG00000166206"}, {"source": "ENSG00000109158", "target": "ENSG00000182256"}, {"source": "ENSG00000109158", "target": "ENSG00000186297"}, {"source": "ENSG00000113327", "target": "ENSG00000115896"}, {"source": "ENSG00000113327", "target": "ENSG00000145863"}, {"source": "ENSG00000113327", "target": "ENSG00000145864"}, {"source": "ENSG00000113327", "target": "ENSG00000151834"}, {"source": "ENSG00000113327", "target": "ENSG00000163288"}, {"source": "ENSG00000113327", "target": "ENSG00000166206"}, {"source": "ENSG00000113327", "target": "ENSG00000182256"}, {"source": "ENSG00000113327", "target": "ENSG00000186297"}, {"source": "ENSG00000115896", "target": "ENSG00000145863"}, {"source": "ENSG00000115896", "target": "ENSG00000145864"}, {"source": "ENSG00000115896", "target": "ENSG00000151834"}, {"source": "ENSG00000115896", "target": "ENSG00000163285"}, {"source": "ENSG00000115896", "target": "ENSG00000163288"}, {"source": "ENSG00000115896", "target": "ENSG00000166206"}, {"source": "ENSG00000115896", "target": "ENSG00000186297"}, {"source": "ENSG00000115896", "target": "ENSG00000187730"}, {"source": "ENSG00000145863", "target": "ENSG00000145864"}, {"source": "ENSG00000145863", "target": "ENSG00000151834"}, {"source": "ENSG00000145863", "target": "ENSG00000163288"}, {"source": "ENSG00000145863", "target": "ENSG00000166206"}, {"source": "ENSG00000145863", "target": "ENSG00000182256"}, {"source": "ENSG00000145863", "target": "ENSG00000186297"}, {"source": "ENSG00000145864", "target": "ENSG00000151834"}, {"source": "ENSG00000145864", "target": "ENSG00000163288"}, {"source": "ENSG00000145864", "target": "ENSG00000166206"}, {"source": "ENSG00000145864", "target": "ENSG00000182256"}, {"source": "ENSG00000145864", "target": "ENSG00000186297"}, {"source": "ENSG00000151834", "target": "ENSG00000163288"}, {"source": "ENSG00000151834", "target": "ENSG00000166206"}, {"source": "ENSG00000151834", "target": "ENSG00000182256"}, {"source": "ENSG00000151834", "target": "ENSG00000186297"}, {"source": "ENSG00000163288", "target": "ENSG00000166206"}, {"source": "ENSG00000163288", "target": "ENSG00000182256"}, {"source": "ENSG00000163288", "target": "ENSG00000186297"}, {"source": "ENSG00000166206", "target": "ENSG00000182256"}, {"source": "ENSG00000166206", "target": "ENSG00000186297"}, {"source": "ENSG00000182256", "target": "ENSG00000186297"}], "drugs": [{"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "RESPIRATORY INSUFFICIENCY", "stage": 3}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "INJURY", "stage": 3}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "LEUKEMIA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "MORBID OBESITY", "stage": 2}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}, {"efo_term": "INSOMNIA", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "PROPOFOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL526", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["LEUKEMIA", "MIGRAINE DISORDER", "MORBID OBESITY", "PAIN", "RESPIRATORY INSUFFICIENCY", "HYPERTENSION", "SUBARACHNOID HEMORRHAGE", "HYPOTENSION", "EPILEPSY", "INJURY", "CORONARY ARTERY DISEASE", "INSOMNIA", "PREMATURE BIRTH", "OBSTRUCTIVE SLEEP APNEA", "UNIPOLAR DEPRESSION", "INFLAMMATION"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "ANXIETY DISORDER", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DEMENTIA", "stage": 1}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "LORAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL580", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY", "DEMENTIA", "EPILEPSY", "UNIPOLAR DEPRESSION", "ANXIETY DISORDER", "ALZHEIMERS DISEASE", "ALCOHOL DEPENDENCE", "DRUG DEPENDENCE", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "CANCER", "stage": 3}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "MORBID OBESITY", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 2}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}, {"efo_term": "HEART DISEASE", "stage": 0}], "max_phase": 4, "name": "SEVOFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200694", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["OBESITY", "ACUTE KIDNEY INJURY", "CANCER", "MORBID OBESITY", "POST-OPERATIVE SIGN OR SYMPTOM", "HEART DISEASE", "INJURY", "CORONARY ARTERY DISEASE", "INFLAMMATION", "CONGENITAL HEART DISEASE"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "DRAVET SYNDROME", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 4, "name": "CLOBAZAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL70418", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY", "DRAVET SYNDROME", "NEUROPATHIC PAIN", "PAIN", "LENNOX-GASTAUT SYNDROME"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "DIAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL12", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "ANXIETY", "PAIN"]}, {"indications": [{"efo_term": "PANIC DISORDER", "stage": 4}, {"efo_term": "ANXIETY", "stage": 4}, {"efo_term": "ANXIETY DISORDER", "stage": 4}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}], "max_phase": 4, "name": "ALPRAZOLAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL661", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["PANIC DISORDER", "ANXIETY", "POST-TRAUMATIC STRESS DISORDER", "ANXIETY DISORDER"]}, {"indications": [{"efo_term": "INJURY", "stage": 3}, {"efo_term": "HEART DISEASE", "stage": 1}, {"efo_term": "DRUG DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "PENTOBARBITAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL448", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["HEART DISEASE", "INJURY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 4, "name": "CLONAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL452", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "EPILEPSY", "MARIJUANA DEPENDENCE"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "CANCER", "stage": 3}], "max_phase": 4, "name": "METHOXYFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1341", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["FEVER", "PAIN", "CANCER"]}, {"indications": [{"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "INSOMNIA", "stage": 1}], "max_phase": 4, "name": "FLUMAZENIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL407", "mechanisms": ["GABA-A receptor; anion channel allosteric antagonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["INSOMNIA", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "STROKE", "stage": 2}], "max_phase": 4, "name": "PRIMIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["EPILEPSY", "STROKE"]}, {"indications": [{"efo_term": "INGUINAL HERNIA", "stage": 3}, {"efo_term": "OPIOID DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "ISOFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["OPIOID DEPENDENCE", "INGUINAL HERNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 2}], "max_phase": 4, "name": "ESZOPICLONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1522", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["INSOMNIA", "OBSTRUCTIVE SLEEP APNEA"]}, {"indications": [{"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}], "max_phase": 4, "name": "DESFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200733", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["POST-OPERATIVE SIGN OR SYMPTOM", "COLORECTAL ADENOCARCINOMA"]}, {"indications": [{"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}], "max_phase": 2, "name": "AZD7325", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1783282", "mechanisms": ["GABA receptor alpha-2 subunit positive allosteric modulator"], "genes": ["GABRA2"], "type": "Small molecule", "diseases": ["AUTISM SPECTRUM DISORDER", "ANXIETY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "METHARBITAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL450", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "CHLORDIAZEPOXIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL451", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "OXAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL568", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 3}], "max_phase": 4, "name": "ETOMIDATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL681", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}], "max_phase": 4, "name": "TEMAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL967", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "PRAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL969", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "HALAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL970", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ANXIETY", "stage": 4}], "max_phase": 4, "name": "MEPROBAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL979", "mechanisms": ["GABA-A receptor; anion channel agonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ANXIETY"]}, {"indications": [{"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 3}], "max_phase": 4, "name": "MIDAZOLAM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200420", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "PF-06372865", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707402", "mechanisms": ["GABA-A receptor; anion channel agonist"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "ADIPIPLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103791", "mechanisms": ["GABA-A receptor; benzodiazepine site partial agonist"], "genes": ["GABRA1", "GABRA4", "GABRG2", "GABRA6", "GABRA2", "GABRG1", "GABRG3", "GABRA5"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "RESEQUINIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107801", "mechanisms": ["GABA-A receptor; benzodiazepine site inverse agonist"], "genes": ["GABRA1", "GABRA4", "GABRG2", "GABRA6", "GABRA2", "GABRG1", "GABRG3", "GABRA5"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 4, "name": "ZALEPLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1521", "mechanisms": ["GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator"], "genes": ["GABRA1", "GABRG2", "GABRB1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 4}], "max_phase": 4, "name": "ZOLPIDEM TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1723343", "mechanisms": ["GABA A receptor alpha-1/beta-1/gamma-2 positive allosteric modulator"], "genes": ["GABRA1", "GABRG2", "GABRB1"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "ETAZOLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL356388", "mechanisms": ["GABA receptor beta-3 subunit positive allosteric modulator"], "genes": ["GABRB3"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [], "max_phase": 3, "name": "INDIPLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL262075", "mechanisms": ["GABA receptor alpha-1 subunit positive allosteric modulator"], "genes": ["GABRA1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUTALBITAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL454", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETHCHLORVYNOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL591", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIAZOLAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL646", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIOPENTAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL738", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHOHEXITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL30219", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ESTAZOLAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL285674", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HALOTHANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL931", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PENTOBARBITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL971", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GLUTETHIMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1102", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ENFLURANE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1257", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUAZEPAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200472", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLURAZEPAM HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200602", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORDIAZEPOXIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200703", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRICLOFOS SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200789", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHYPRYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200790", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TALBUTAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200802", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SECOBARBITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200903", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BUTABARBITAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200982", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIAMYLAL SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201065", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ACAMPROSATE CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2068724", "mechanisms": ["GABA-A receptor; anion channel positive modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CLORAZEPATE DIPOTASSIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096631", "mechanisms": ["GABA-A receptor; anion channel positive allosteric modulator"], "genes": ["GABRA1", "GABRP", "GABRE", "GABRA4", "GABRG2", "GABRA6", "GABRB2", "GABRA2", "GABRG1", "GABRB1", "GABRB3", "GABRG3", "GABRA5", "GABRD"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "Lorediplon", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707317", "mechanisms": ["GABA-A receptor; benzodiazepine site positive allosteric modulator"], "genes": ["GABRA1", "GABRA4", "GABRG2", "GABRA6", "GABRA2", "GABRG1", "GABRG3", "GABRA5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "GABOXADOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL312443", "mechanisms": ["GABA-A receptor; agonist GABA site agonist"], "genes": ["GABRA1", "GABRA4", "GABRA6", "GABRB2", "GABRA2", "GABRB1", "GABRB3", "GABRA5"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AZD6280", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1783256", "mechanisms": ["GABA receptor alpha-2 subunit positive allosteric modulator"], "genes": ["GABRA2"], "type": "Small molecule", "diseases": []}], "heat": 0.21621238847780003, "nodes": [{"assoc": 0.250786232936, "id": "ENSG00000022355", "label": "GABRA1"}, {"assoc": 0.136111111111, "id": "ENSG00000094755", "label": "GABRP"}, {"assoc": 0.136111111111, "id": "ENSG00000102287", "label": "GABRE"}, {"assoc": 0.242361111111, "id": "ENSG00000109158", "label": "GABRA4"}, {"assoc": 0.244841925849, "id": "ENSG00000113327", "label": "GABRG2"}, {"assoc": 0.213264667, "id": "ENSG00000115896", "label": "PLCL1"}, {"assoc": 0.242361111111, "id": "ENSG00000145863", "label": "GABRA6"}, {"assoc": 0.136111111111, "id": "ENSG00000145864", "label": "GABRB2"}, {"assoc": 0.388322277778, "id": "ENSG00000151834", "label": "GABRA2"}, {"assoc": 0.245961111111, "id": "ENSG00000163285", "label": "GABRG1"}, {"assoc": 0.136111111111, "id": "ENSG00000163288", "label": "GABRB1"}, {"assoc": 0.244725265894, "id": "ENSG00000166206", "label": "GABRB3"}, {"assoc": 0.246643381011, "id": "ENSG00000182256", "label": "GABRG3"}, {"assoc": 0.243363187811, "id": "ENSG00000186297", "label": "GABRA5"}, {"assoc": 0.136111111111, "id": "ENSG00000187730", "label": "GABRD"}], "size": 15}, {"diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION", "MEMORY IMPAIRMENT", "PARKINSON'S DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "SARCOIDOSIS", "ALCOHOL DRINKING", "HEART FAILURE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CERVICAL CARCINOMA", "COGNITIVE IMPAIRMENT", "LUNG CARCINOMA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "INJURY", "DRUG DEPENDENCE", "ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "NEUROPATHIC PAIN", "UNIPOLAR DEPRESSION", "HYPERTENSION", "OVERACTIVE BLADDER", "GASTROPARESIS", "IRRITABLE BOWEL SYNDROME", "LIVER DISEASE", "TYPE II DIABETES MELLITUS", "ASTHMA"], "links": [{"source": "ENSG00000101204", "target": "ENSG00000147434"}, {"source": "ENSG00000101204", "target": "ENSG00000160716"}, {"source": "ENSG00000101204", "target": "ENSG00000163032"}, {"source": "ENSG00000101204", "target": "ENSG00000169684"}, {"source": "ENSG00000101204", "target": "ENSG00000175344"}, {"source": "ENSG00000147434", "target": "ENSG00000160716"}, {"source": "ENSG00000147434", "target": "ENSG00000169684"}, {"source": "ENSG00000147434", "target": "ENSG00000175344"}, {"source": "ENSG00000160716", "target": "ENSG00000169684"}, {"source": "ENSG00000160716", "target": "ENSG00000175344"}, {"source": "ENSG00000169684", "target": "ENSG00000175344"}], "drugs": [{"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 4}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "CERVICAL CARCINOMA", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "MEMORY IMPAIRMENT", "stage": 1}, {"efo_term": "SARCOIDOSIS", "stage": 1}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}], "max_phase": 4, "name": "NICOTINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION", "MEMORY IMPAIRMENT", "PARKINSON'S DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "SARCOIDOSIS", "ALCOHOL DRINKING", "HEART FAILURE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CERVICAL CARCINOMA", "COGNITIVE IMPAIRMENT", "LUNG CARCINOMA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "INJURY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "ISPRONICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL188462", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 1}], "max_phase": 3, "name": "DEXMECAMYLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103881", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 antagonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["HYPERTENSION", "OVERACTIVE BLADDER", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}], "max_phase": 2, "name": "POZANICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL127071", "mechanisms": ["Nicotinic acetylcholine receptor alpha4/beta2/alpha5 partial agonist", "Neuronal acetylcholine receptor; alpha6/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNA6", "CHRNB2", "CHRNA5"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 2, "name": "BRADANICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1258006", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "SOFINICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL238465", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}], "max_phase": 4, "name": "NICOTINE POLACRILEX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201536", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 1}], "max_phase": 4, "name": "VARENICLINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062259", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["NICOTINE DEPENDENCE", "SMOKING CESSATION"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}], "max_phase": 2, "name": "AZD1446", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2179529", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [{"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "GASTROPARESIS", "stage": 1}], "max_phase": 2, "name": "TC-6499", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545353", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": ["GASTROPARESIS", "IRRITABLE BOWEL SYNDROME"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 2, "name": "AZD0328", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2151437", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "ABT-126", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545231", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "SMOKING CESSATION", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "JNJ-39393406", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545291", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SMOKING CESSATION", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "TC-6987", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545410", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS", "ASTHMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 2, "name": "ASM-024", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707249", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit modulator"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 1}], "max_phase": 1, "name": "AVL-3288", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL429317", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "SSR180711", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL559478", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "ENCENICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2151572", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["LIVER DISEASE"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "RG3487", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544952", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 1}], "max_phase": 1, "name": "APN1125", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545013", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "AQW051", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545232", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 1}], "max_phase": 0, "name": "ND0801", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707316", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": ["ATTENTION DEFICIT HYPERACTIVITY DISORDER"]}, {"indications": [], "max_phase": 2, "name": "TEBANICLINE TOSYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL430497", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ALTINICLINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL111659", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "TC-2216", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL504652", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 antagonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CP-601927", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707250", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 partial agonist"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "ABT-560", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707354", "mechanisms": ["Neuronal acetylcholine receptor; alpha4/beta2 modulator"], "genes": ["CHRNA4", "CHRNB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "PHA-543613", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL214268", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "ABT-107", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2151570", "mechanisms": ["Neuronal acetylcholine receptor protein alpha-7 subunit agonist"], "genes": ["CHRNA7"], "type": "Small molecule", "diseases": []}], "heat": 0.6402285856378335, "nodes": [{"assoc": 1.0, "id": "ENSG00000101204", "label": "CHRNA4"}, {"assoc": 0.275534222222, "id": "ENSG00000147434", "label": "CHRNA6"}, {"assoc": 1.0, "id": "ENSG00000160716", "label": "CHRNB2"}, {"assoc": 0.293615069383, "id": "ENSG00000163032", "label": "VSNL1"}, {"assoc": 0.272222222222, "id": "ENSG00000169684", "label": "CHRNA5"}, {"assoc": 1.0, "id": "ENSG00000175344", "label": "CHRNA7"}], "size": 6}, {"diseases": ["EPILEPSY", "SEIZURES", "INJURY", "OPTIC NEURITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "BREAST CARCINOMA", "POST-OPERATIVE SIGN OR SYMPTOM", "CANCER", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "OSTEOARTHRITIS", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "PULMONARY HYPERTENSION", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "PREGNANCY", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA", "CATARACT", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "DRUG DEPENDENCE", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "OBSESSIVE-COMPULSIVE DISORDER", "ALCOHOL DEPENDENCE", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "NICOTINE DEPENDENCE", "MIGRAINE DISORDER", "NEUROPATHY", "DIABETIC NEUROPATHY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA", "COMPLEX PARTIAL EPILEPSY", "ALCOHOL DRINKING", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "SMOKING CESSATION", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA", "DYSURIA", "ATRIAL FIBRILLATION", "HIP FRACTURE", "INGUINAL HERNIA", "BONE FRACTURE", "CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE"], "links": [{"source": "ENSG00000136531", "target": "ENSG00000183873"}, {"source": "ENSG00000136531", "target": "ENSG00000185313"}, {"source": "ENSG00000136531", "target": "ENSG00000196876"}, {"source": "ENSG00000183873", "target": "ENSG00000185313"}, {"source": "ENSG00000183873", "target": "ENSG00000196876"}, {"source": "ENSG00000185313", "target": "ENSG00000196876"}, {"source": "ENSG00000169432", "type": "manual", "target": "ENSG00000149575"}, {"source": "ENSG00000149575", "type": "manual", "target": "ENSG00000196876"}, {"source": "ENSG00000153253", "type": "manual", "target": "ENSG00000166257"}, {"source": "ENSG00000166257", "type": "manual", "target": "ENSG00000196876"}], "drugs": [{"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "PERIPHERAL NEUROPATHY", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "CARPAL TUNNEL SYNDROME", "stage": 3}, {"efo_term": "COUGH", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 3}, {"efo_term": "PARATHYROID DISEASE", "stage": 3}, {"efo_term": "PREECLAMPSIA", "stage": 3}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 3}, {"efo_term": "PREMATURE EJACULATION", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "NUTRITIONAL DISORDER", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "OVERACTIVE BLADDER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "CARCINOMA", "stage": 2}, {"efo_term": "URINARY TRACT INFECTION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "ANXIETY", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DYSMENORRHEA", "stage": 2}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "UTERINE FIBROID", "stage": 2}, {"efo_term": "AGE-RELATED MACULAR DEGENERATION", "stage": 2}, {"efo_term": "STROKE", "stage": 2}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 2}, {"efo_term": "PREMATURE BIRTH", "stage": 1}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 1}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}, {"efo_term": "TINNITUS", "stage": 0}], "max_phase": 4, "name": "LIDOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL79", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "PAIN", "PERIPHERAL NEUROPATHY", "SUDDEN CARDIAC ARREST", "SYSTEMIC SCLERODERMA", "CARCINOMA", "PREMATURE BIRTH", "URINARY TRACT INFECTION", "BREAST CARCINOMA", "POST-OPERATIVE SIGN OR SYMPTOM", "CANCER", "CARPAL TUNNEL SYNDROME", "COUGH", "PRURITUS", "TINNITUS", "ANXIETY", "FIBROMYALGIA", "COCAINE DEPENDENCE", "DYSMENORRHEA", "NEUROPATHIC PAIN", "PARATHYROID DISEASE", "PREECLAMPSIA", "OSTEOARTHRITIS", "POSTMENOPAUSAL OSTEOPOROSIS", "PREMATURE EJACULATION", "TENDINOPATHY", "CARDIAC ARRHYTHMIA", "OBESITY", "UTERINE FIBROID", "AGE-RELATED MACULAR DEGENERATION", "FROZEN SHOULDER", "PULMONARY HYPERTENSION", "STROKE", "NUTRITIONAL DISORDER", "ARTHRITIS", "MYALGIA", "PREGNANCY", "OVERACTIVE BLADDER", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "SMOKING CESSATION", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "PRADER-WILLI SYNDROME", "stage": 3}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "ALCOHOL DRINKING", "stage": 2}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 2}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 2}, {"efo_term": "MARIJUANA DEPENDENCE", "stage": 2}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}, {"efo_term": "CONGENITAL HEART DISEASE", "stage": 1}], "max_phase": 4, "name": "TOPIRAMATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL220492", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["COCAINE DEPENDENCE", "EPILEPSY", "ALCOHOL DRINKING", "BIPOLAR DISORDER", "MIGRAINE DISORDER", "ALCOHOL DEPENDENCE", "CONGENITAL HEART DISEASE", "METAMPHETAMINE DEPENDENCE", "GAMBLING BEHAVIOUR", "OBESITY", "SMOKING CESSATION", "NICOTINE DEPENDENCE", "MARIJUANA DEPENDENCE", "PRADER-WILLI SYNDROME", "CEREBRAL ISCHEMIA"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "GENERALIZED TONIC-CLONIC SEIZURES", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "MOOD DISORDER", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 1}], "max_phase": 4, "name": "LAMOTRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EPILEPSY", "FISH-EYE DISEASE", "MENTAL OR BEHAVIOURAL DISORDER", "MOOD DISORDER", "UNIPOLAR DEPRESSION", "NEUROFIBROMATOSIS TYPE 1", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "SEIZURES", "LENNOX-GASTAUT SYNDROME", "GENERALIZED TONIC-CLONIC SEIZURES", "PARTIAL EPILEPSY", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "MYOCARDIAL ISCHEMIA", "stage": 3}, {"efo_term": "DILATED CARDIOMYOPATHY", "stage": 2}, {"efo_term": "ACUTE CORONARY SYNDROME", "stage": 2}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 2}, {"efo_term": "PROLONGED QT INTERVAL", "stage": 2}, {"efo_term": "VASCULAR DISEASE", "stage": 2}, {"efo_term": "DIASTOLIC HEART FAILURE", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 1}], "max_phase": 4, "name": "RANOLAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1404", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": ["CORONARY ARTERY DISEASE", "DILATED CARDIOMYOPATHY", "TYPE II DIABETES MELLITUS", "ATRIAL FIBRILLATION", "ACUTE CORONARY SYNDROME", "IRRITABLE BOWEL SYNDROME", "PROLONGED QT INTERVAL", "PULMONARY HYPERTENSION", "CARDIOVASCULAR DISEASE", "VASCULAR DISEASE", "ANGINA PECTORIS", "MYOCARDIAL ISCHEMIA", "DIASTOLIC HEART FAILURE"]}, {"indications": [{"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ATAXIA", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "PROXIMAL SPINAL MUSCULAR ATROPHY", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 1}, {"efo_term": "CANCER", "stage": 1}], "max_phase": 4, "name": "RILUZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL744", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "POST-TRAUMATIC STRESS DISORDER", "ATAXIA", "AUTISM SPECTRUM DISORDER", "BIPOLAR DISORDER", "UNIPOLAR DEPRESSION", "ALZHEIMERS DISEASE", "CUTANEOUS MELANOMA", "PROXIMAL SPINAL MUSCULAR ATROPHY", "AMYOTROPHIC LATERAL SCLEROSIS", "CANCER", "OBSESSIVE-COMPULSIVE DISORDER"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "NEUROPATHY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}], "max_phase": 4, "name": "LACOSAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL58323", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "OSTEOARTHRITIS", "PARTIAL EPILEPSY", "MIGRAINE DISORDER", "NEUROPATHY", "NEUROPATHIC PAIN", "FIBROMYALGIA", "SEIZURES", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "COMPLEX PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 3}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}], "max_phase": 4, "name": "ESLICARBAZEPINE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL87992", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "FIBROMYALGIA", "MIGRAINE DISORDER", "BIPOLAR DISORDER", "COMPLEX PARTIAL EPILEPSY", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "ESSENTIAL TREMOR", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ZONISAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL750", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "EPILEPSY", "PARKINSON'S DISEASE", "EATING DISORDER", "ESSENTIAL TREMOR", "SEIZURES", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 3}, {"efo_term": "SEIZURES", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 4, "name": "OXCARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1068", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "PARTIAL EPILEPSY", "MULTIPLE SCLEROSIS", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "SEIZURES", "stage": 4}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}], "max_phase": 4, "name": "PHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL16", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "SEIZURES", "INJURY", "OPTIC NEURITIS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "PARTIAL EPILEPSY", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "TRIGEMINAL NEURALGIA", "stage": 4}], "max_phase": 4, "name": "CARBAMAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL108", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "PARTIAL EPILEPSY", "BIPOLAR DISORDER", "TRIGEMINAL NEURALGIA"]}, {"indications": [{"efo_term": "PRURITUS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "CATARACT", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "TETRACAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL698", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CATARACT", "PAIN", "PRURITUS"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "LENNOX-GASTAUT SYNDROME", "stage": 4}, {"efo_term": "SEIZURES", "stage": 3}, {"efo_term": "PAIN", "stage": 2}], "max_phase": 4, "name": "RUFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201754", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SEIZURES", "EPILEPSY", "LENNOX-GASTAUT SYNDROME", "PAIN"]}, {"indications": [{"efo_term": "HIP FRACTURE", "stage": 2}, {"efo_term": "BONE FRACTURE", "stage": 2}, {"efo_term": "INGUINAL HERNIA", "stage": 1}, {"efo_term": "PAIN", "stage": 0}], "max_phase": 4, "name": "ROPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1889140", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "HIP FRACTURE", "INGUINAL HERNIA", "BONE FRACTURE"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}, {"efo_term": "STROKE", "stage": 2}], "max_phase": 4, "name": "PRIMIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL856", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY", "STROKE"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}], "max_phase": 3, "name": "RALFINAMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107771", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PAIN", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "TRIGEMINAL NEURALGIA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 1}], "max_phase": 2, "name": "RAXATRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544913", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["TRIGEMINAL NEURALGIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}, {"efo_term": "DIABETIC NEUROPATHY", "stage": 2}], "max_phase": 2, "name": "PF-05089771", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545171", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["PAIN", "DIABETIC NEUROPATHY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "MEPHENYTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL861", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "PHENACEMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL918", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ESLICARBAZEPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL315985", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "EPILEPSY", "stage": 4}], "max_phase": 4, "name": "ETHOTOIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1095", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["EPILEPSY"]}, {"indications": [{"efo_term": "DYSURIA", "stage": 3}], "max_phase": 4, "name": "PHENAZOPYRIDINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201022", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["DYSURIA"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}], "max_phase": 4, "name": "ORPHENADRINE (CHLORIDE)", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201023", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "CARDIAC ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "QUINIDINE POLYGALACTURONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201486", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 4}], "max_phase": 4, "name": "DRONEDARONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201729", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}], "max_phase": 2, "name": "NERISPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107762", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["MULTIPLE SCLEROSIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 2, "name": "NW-3509", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545207", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "NEUROPATHIC PAIN", "stage": 1}], "max_phase": 1, "name": "AZD3161", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545208", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": ["NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ATRIAL FIBRILLATION", "stage": 2}], "max_phase": 2, "name": "AZD1305", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545169", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION"]}, {"indications": [{"efo_term": "PAIN", "stage": 2}], "max_phase": 2, "name": "PF-04531083", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544951", "mechanisms": ["Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN10A"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [], "max_phase": 0, "name": "ELPETRIGINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29919", "mechanisms": ["Sodium channel protein type II alpha subunit blocker", "Sodium channel protein type III alpha subunit blocker"], "genes": ["SCN2A", "SCN3A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCAINAMIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "IRAMPANEL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL29741", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FOSPHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL919", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLOROPROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL944", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1194", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYTOIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1611", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPOXYCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1769", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MORICIZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200334", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "INDECAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200341", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ORPHENADRINE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200395", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LIDOCAINE HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200409", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE GLUCONATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200437", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPIVACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200440", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MERETHOXYLLINE PROCAINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200443", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPARACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200464", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DYCLONINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200478", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRILOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200586", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ETIDOCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200597", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEXILETINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200606", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BENOXINATE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HEXYLCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200715", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOCAINIDE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200773", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ARTICAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200819", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200841", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DISOPYRAMIDE PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201020", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRACAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1255654", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "NKTR-171", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545209", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINIDINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707183", "mechanisms": ["Sodium channel alpha subunit blocker"], "genes": ["SCN2A", "SCN3A", "SCN9A", "SCN5A", "SCN10A", "SCN8A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "DSP-2230", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545012", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN9A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "XEN403", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545091", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG7893", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707353", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 0, "name": "RG6029", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3707380", "mechanisms": ["Sodium channel protein type IX alpha subunit blocker"], "genes": ["SCN9A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIBUCAINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200612", "mechanisms": ["Sodium channel protein type V alpha subunit blocker", "Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN5A", "SCN10A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLECAINIDE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200822", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AZD7009", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545040", "mechanisms": ["Sodium channel protein type V alpha subunit blocker"], "genes": ["SCN5A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Afacifenacin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545165", "mechanisms": ["Sodium channel protein type X alpha subunit blocker"], "genes": ["SCN10A"], "type": "Small molecule", "diseases": []}], "heat": 0.75, "nodes": [{"assoc": 1.0, "id": "ENSG00000136531", "label": "SCN2A"}, {"assoc": 1.0, "id": "ENSG00000153253", "label": "SCN3A"}, {"assoc": 1.0, "id": "ENSG00000169432", "label": "SCN9A"}, {"assoc": 1.0, "id": "ENSG00000183873", "label": "SCN5A"}, {"assoc": 1.0, "id": "ENSG00000185313", "label": "SCN10A"}, {"assoc": 1.0, "id": "ENSG00000196876", "label": "SCN8A"}, {"assoc": 0, "id": "ENSG00000149575", "label": "SCN2B"}, {"assoc": 0, "id": "ENSG00000166257", "label": "SCN3B"}], "size": 8}, {"diseases": [], "links": [{"source": "ENSG00000005421", "target": "ENSG00000120885"}, {"source": "ENSG00000120885", "target": "ENSG00000123191"}, {"source": "ENSG00000120885", "target": "ENSG00000142185"}], "drugs": [], "heat": 0.267022416768575, "nodes": [{"assoc": 0.0849181330234, "id": "ENSG00000005421", "label": "PON1"}, {"assoc": 0.869584982585, "id": "ENSG00000120885", "label": "CLU"}, {"assoc": 0.0516324664659, "id": "ENSG00000123191", "label": "ATP7B"}, {"assoc": 0.061954085, "id": "ENSG00000142185", "label": "TRPM2"}], "size": 4}, {"diseases": ["ANGINA PECTORIS", "HYPERTENSION", "MYOCARDIAL INFARCTION", "MARFAN SYNDROME", "HEART DISEASE", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "OCULAR HYPERTENSION", "SKIN ULCER", "UNIPOLAR DEPRESSION", "ASTHMA", "SMOKING CESSATION", "PARKINSON'S DISEASE", "TYPE II DIABETES MELLITUS", "CUTANEOUS MELANOMA", "AORTIC STENOSIS", "HEART FAILURE", "CONGESTIVE HEART FAILURE", "FISH-EYE DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "VENTRICULAR ARRHYTHMIA", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "OVARIAN CYST", "DIABETIC FOOT", "OBESITY", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "PREECLAMPSIA", "RENAL INSUFFICIENCY", "HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CHRONIC KIDNEY DISEASE", "MULTIPLE SYSTEM ATROPHY", "ALZHEIMERS DISEASE", "SCHIZOPHRENIA", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "CONGENITAL MYASTHENIC SYNDROME", "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "MEMORY IMPAIRMENT", "IDIOPATHIC PULMONARY FIBROSIS", "FAMILIAL DYSAUTONOMIA", "RESPIRATORY FAILURE", "INFLAMMATION", "EMPHYSEMA", "CHRONIC BRONCHITIS", "DRUG DEPENDENCE", "ACUTE RESPIRATORY DISTRESS SYNDROME", "PAIN", "LIVER DISEASE", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS"], "links": [{"source": "ENSG00000043591", "target": "ENSG00000158748"}, {"source": "ENSG00000043591", "target": "ENSG00000169252"}, {"source": "ENSG00000043591", "target": "ENSG00000188778"}, {"source": "ENSG00000158748", "target": "ENSG00000169252"}, {"source": "ENSG00000158748", "target": "ENSG00000188778"}, {"source": "ENSG00000169252", "target": "ENSG00000188778"}], "drugs": [{"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 3}, {"efo_term": "FAMILIAL DYSAUTONOMIA", "stage": 3}, {"efo_term": "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "stage": 2}, {"efo_term": "MEMORY IMPAIRMENT", "stage": 2}, {"efo_term": "RESPIRATORY FAILURE", "stage": 2}, {"efo_term": "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "stage": 1}, {"efo_term": "CONGENITAL MYASTHENIC SYNDROME", "stage": 1}, {"efo_term": "IDIOPATHIC PULMONARY FIBROSIS", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "ALBUTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL714", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "CONGESTIVE HEART FAILURE", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "CONGENITAL MYASTHENIC SYNDROME", "IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION", "MEMORY IMPAIRMENT", "IDIOPATHIC PULMONARY FIBROSIS", "OBSTRUCTIVE LUNG DISEASE", "FAMILIAL DYSAUTONOMIA", "RESPIRATORY FAILURE", "INFLAMMATION"]}, {"indications": [{"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "MARFAN SYNDROME", "stage": 3}, {"efo_term": "HEART DISEASE", "stage": 3}, {"efo_term": "HEMANGIOMA", "stage": 3}], "max_phase": 4, "name": "ATENOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["ANGINA PECTORIS", "HYPERTENSION", "MYOCARDIAL INFARCTION", "MARFAN SYNDROME", "HEART DISEASE", "CARDIOVASCULAR DISEASE", "HEMANGIOMA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "ANGINA PECTORIS", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "AORTIC STENOSIS", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "METOPROLOL SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200337", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "AORTIC STENOSIS", "HEART FAILURE", "CONGESTIVE HEART FAILURE", "FISH-EYE DISEASE", "ANGINA PECTORIS", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 4}, {"efo_term": "CHRONIC INTERSTITIAL CYSTITIS", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "NEUROGENIC BLADDER", "stage": 2}, {"efo_term": "LEFT VENTRICULAR HYPERTROPHY", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "MIRABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2095212", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["HEART FAILURE", "PAIN", "LIVER DISEASE", "OVERACTIVE BLADDER", "NEUROGENIC BLADDER", "LEFT VENTRICULAR HYPERTROPHY", "CHRONIC INTERSTITIAL CYSTITIS"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}, {"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 2}, {"efo_term": "HEMANGIOMA", "stage": 2}, {"efo_term": "SKIN ULCER", "stage": 2}], "max_phase": 4, "name": "TIMOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL499", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["GLAUCOMA", "OPEN-ANGLE GLAUCOMA", "CARDIOVASCULAR DISEASE", "HEMANGIOMA", "OCULAR HYPERTENSION", "SKIN ULCER"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "OBESITY", "stage": 2}], "max_phase": 4, "name": "SALMETEROL XINAFOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1082607", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "OBESITY", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}], "max_phase": 4, "name": "ALBUTEROL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201026", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 2}], "max_phase": 4, "name": "NADOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL649", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CARDIOVASCULAR DISEASE", "SMOKING CESSATION", "HEMANGIOMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}], "max_phase": 4, "name": "VILANTEROL TRIFENATATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1084172", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}, {"efo_term": "CHRONIC BRONCHITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 2}], "max_phase": 4, "name": "INDACATEROL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1789842", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA", "EMPHYSEMA", "CHRONIC BRONCHITIS"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 2}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 1}], "max_phase": 4, "name": "PROPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1671", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS", "HYPERTENSION", "CUTANEOUS MELANOMA"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 3}, {"efo_term": "HEMANGIOMA", "stage": 3}, {"efo_term": "ANTERIOR ISCHEMIC OPTIC NEUROPATHY", "stage": 1}], "max_phase": 4, "name": "TIMOLOL MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200870", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["GLAUCOMA", "HEMANGIOMA", "ANTERIOR ISCHEMIC OPTIC NEUROPATHY"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201167", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["HYPERTENSION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 4, "name": "PINDOLOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL500", "mechanisms": ["Beta-1 adrenergic receptor partial agonist", "Beta-2 adrenergic receptor partial agonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE", "UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}, {"efo_term": "OCULAR HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "BETAXOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1691", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA", "OCULAR HYPERTENSION"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "BISOPROLOL FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200708", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "FISH-EYE DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "VENTRICULAR ARRHYTHMIA", "stage": 4}], "max_phase": 4, "name": "ACEBUTOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200813", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["HYPERTENSION", "VENTRICULAR ARRHYTHMIA"]}, {"indications": [{"efo_term": "OVARIAN CYST", "stage": 1}, {"efo_term": "DIABETIC FOOT", "stage": 1}], "max_phase": 4, "name": "ESMOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201115", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["OVARIAN CYST", "DIABETIC FOOT"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}], "max_phase": 3, "name": "IDALOPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3286580", "mechanisms": ["Serotonin 6 (5-HT6) receptor antagonist"], "genes": ["HTR6"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}], "max_phase": 4, "name": "TERBUTALINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1160544", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "DRUG DEPENDENCE", "stage": 2}], "max_phase": 4, "name": "METAPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200812", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "DRUG DEPENDENCE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}], "max_phase": 4, "name": "ARFORMOTEROL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1951071", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}, {"efo_term": "EMPHYSEMA", "stage": 4}], "max_phase": 4, "name": "OLODATEROL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105743", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "EMPHYSEMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 2, "name": "BEDORADRINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218893", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ASTHMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 4}], "max_phase": 4, "name": "FORMOTEROL FUMARATE DIHYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2303638", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "ABEDITEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039530", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "AZD3199", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545103", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 3}], "max_phase": 4, "name": "DOPAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1557", "mechanisms": ["Beta-1 adrenergic receptor agonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "NEBIVOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201731", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}], "max_phase": 4, "name": "METOPROLOL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256957", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": ["MYOCARDIAL INFARCTION"]}, {"indications": [{"efo_term": "OBESITY", "stage": 2}], "max_phase": 2, "name": "LY377604", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2012520", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist", "Beta-3 adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["OBESITY"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "ISOPROTERENOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1711", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "OPEN-ANGLE GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "CARTEOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201002", "mechanisms": ["Adrenergic receptor beta antagonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["OPEN-ANGLE GLAUCOMA"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "SB-742457", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1083390", "mechanisms": ["Serotonin 6 (5-HT6) receptor antagonist"], "genes": ["HTR6"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "CERLAPIRDINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103880", "mechanisms": ["Serotonin 6 (5-HT6) receptor antagonist"], "genes": ["HTR6"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 2, "name": "PF-05212377", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545344", "mechanisms": ["Serotonin 6 (5-HT6) receptor antagonist"], "genes": ["HTR6"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "CARMOTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1094785", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "PIRBUTEROL ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200444", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 3}], "max_phase": 4, "name": "LEVALBUTEROL TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062258", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}], "max_phase": 2, "name": "BATEFENTEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3039518", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE"]}, {"indications": [{"efo_term": "NEUROGENIC BLADDER", "stage": 1}], "max_phase": 3, "name": "RITOBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107773", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["NEUROGENIC BLADDER"]}, {"indications": [{"efo_term": "OVERACTIVE BLADDER", "stage": 2}], "max_phase": 2, "name": "VIBEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107826", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": ["OVERACTIVE BLADDER"]}, {"indications": [], "max_phase": 4, "name": "SOTALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1700", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PENBUTOLOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200363", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOBUTAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200418", "mechanisms": ["Beta-1 adrenergic receptor agonist", "Beta-2 adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXPRENOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200745", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOBETAXOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200837", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METOPROLOL FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200898", "mechanisms": ["Beta-1 adrenergic receptor antagonist"], "genes": ["ADRB1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METIPRANOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200947", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROPAFENONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201063", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVOBUNOLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201177", "mechanisms": ["Beta-1 adrenergic receptor antagonist", "Beta-2 adrenergic receptor antagonist"], "genes": ["ADRB1", "ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOPROTERENOL SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200447", "mechanisms": ["Adrenergic receptor beta agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRB1", "ADRB2", "ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BITOLTEROL MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200405", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROTOKYLOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200893", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOETHARINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200920", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LEVALBUTEROL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201061", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ISOETHARINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201153", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "RITODRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201160", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "MILVETEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1940832", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "GSK159802", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545087", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "LAS190792", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545272", "mechanisms": ["Beta-2 adrenergic receptor agonist"], "genes": ["ADRB2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "RAFABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL279260", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SOLABEGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL208427", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "AMIBEGRON HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL545437", "mechanisms": ["Beta-3 adrenergic receptor agonist"], "genes": ["ADRB3"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000043591", "label": "ADRB1"}, {"assoc": 1.0, "id": "ENSG00000158748", "label": "HTR6"}, {"assoc": 1.0, "id": "ENSG00000169252", "label": "ADRB2"}, {"assoc": 1.0, "id": "ENSG00000188778", "label": "ADRB3"}], "size": 4}, {"diseases": ["HYPOTENSION", "HEART FAILURE", "PARKINSON'S DISEASE", "ORTHOSTATIC HYPOTENSION", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "GLAUCOMA", "MYASTHENIA GRAVIS", "ALZHEIMERS DISEASE", "DEMENTIA", "AUTISM", "MIGRAINE DISORDER", "DOWN SYNDROME", "COCAINE DEPENDENCE", "PROGRESSIVE SUPRANUCLEAR PALSY", "METAMPHETAMINE DEPENDENCE", "DROOLING", "HYPERHIDROSIS"], "links": [{"source": "ENSG00000070748", "target": "ENSG00000137968"}, {"source": "ENSG00000087085", "target": "ENSG00000137968"}, {"source": "ENSG00000114200", "type": "manual", "target": "ENSG00000206561"}, {"source": "ENSG00000206561", "type": "manual", "target": "ENSG00000087085"}, {"source": "ENSG00000114200", "type": "manual", "target": "ENSG00000254647"}, {"source": "ENSG00000254647", "type": "manual", "target": "ENSG00000220205"}, {"source": "ENSG00000220205", "type": "manual", "target": "ENSG00000070748"}], "drugs": [{"indications": [{"efo_term": "DEMENTIA", "stage": 4}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "PARKINSON'S DISEASE", "stage": 3}, {"efo_term": "PROGRESSIVE SUPRANUCLEAR PALSY", "stage": 3}, {"efo_term": "DOWN SYNDROME", "stage": 1}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}, {"efo_term": "METAMPHETAMINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "RIVASTIGMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL636", "mechanisms": ["Cholinesterases; ACHE & BCHE inhibitor"], "genes": ["ACHE", "BCHE"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "PARKINSON'S DISEASE", "DEMENTIA", "DOWN SYNDROME", "COCAINE DEPENDENCE", "PROGRESSIVE SUPRANUCLEAR PALSY", "METAMPHETAMINE DEPENDENCE"]}, {"indications": [{"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 2}, {"efo_term": "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY", "stage": 0}], "max_phase": 4, "name": "PYRIDOSTIGMINE BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL812", "mechanisms": ["Acetylcholinesterase inhibitor"], "genes": ["ACHE"], "type": "Small molecule", "diseases": ["HYPOTENSION", "HEART FAILURE", "PARKINSON'S DISEASE", "ORTHOSTATIC HYPOTENSION", "GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY"]}, {"indications": [{"efo_term": "ALZHEIMERS DISEASE", "stage": 4}, {"efo_term": "DEMENTIA", "stage": 4}, {"efo_term": "DOWN SYNDROME", "stage": 3}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}], "max_phase": 4, "name": "DONEPEZIL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1678", "mechanisms": ["Acetylcholinesterase inhibitor"], "genes": ["ACHE"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "DEMENTIA", "AUTISM", "MIGRAINE DISORDER", "DOWN SYNDROME"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "DEMENTIA", "stage": 4}], "max_phase": 4, "name": "RIVASTIGMINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL215645", "mechanisms": ["Cholinesterases; ACHE & BCHE inhibitor"], "genes": ["ACHE", "BCHE"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "DEMENTIA"]}, {"indications": [{"efo_term": "DROOLING", "stage": 3}, {"efo_term": "HYPERHIDROSIS", "stage": 2}], "max_phase": 4, "name": "BOTULINUM TOXIN TYPE B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201569", "mechanisms": ["Vesicle-associated membrane protein 2 inhibitor"], "genes": ["VAMP2"], "type": "Unknown", "diseases": ["DROOLING", "HYPERHIDROSIS"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "ISOFLUROPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1025", "mechanisms": ["Acetylcholinesterase inhibitor"], "genes": ["ACHE"], "type": "Small molecule", "diseases": ["GLAUCOMA"]}, {"indications": [{"efo_term": "MYASTHENIA GRAVIS", "stage": 4}], "max_phase": 4, "name": "NEOSTIGMINE METHYLSULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL211471", "mechanisms": ["Acetylcholinesterase inhibitor"], "genes": ["ACHE"], "type": "Small molecule", "diseases": ["MYASTHENIA GRAVIS"]}, {"indications": [{"efo_term": "GLAUCOMA", "stage": 4}], "max_phase": 4, "name": "ECHOTHIOPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201341", "mechanisms": ["Acetylcholinesterase inhibitor"], "genes": ["ACHE"], "type": "Small molecule", "diseases": ["GLAUCOMA"]}, {"indications": [], "max_phase": 4, "name": "PRALIDOXIME CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL748", "mechanisms": ["Acetylcholinesterase activator"], "genes": ["ACHE"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EDROPHONIUM CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1128", "mechanisms": ["Acetylcholinesterase inhibitor"], "genes": ["ACHE"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "GALANTAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1555", "mechanisms": ["Acetylcholinesterase inhibitor"], "genes": ["ACHE"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ECHOTHIOPHATE IODIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200367", "mechanisms": ["Acetylcholinesterase inhibitor"], "genes": ["ACHE"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DEMECARIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200514", "mechanisms": ["Acetylcholinesterase inhibitor"], "genes": ["ACHE"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMBENONIUM CHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200541", "mechanisms": ["Acetylcholinesterase inhibitor"], "genes": ["ACHE"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HEXAFLUORENIUM BROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200933", "mechanisms": ["Acetylcholinesterase inhibitor"], "genes": ["ACHE"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TACRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1677", "mechanisms": ["Cholinesterases; ACHE & BCHE inhibitor"], "genes": ["ACHE", "BCHE"], "type": "Small molecule", "diseases": []}], "heat": 0.31152046311057147, "nodes": [{"assoc": 0.133079638074, "id": "ENSG00000070748", "label": "CHAT"}, {"assoc": 1.0, "id": "ENSG00000087085", "label": "ACHE"}, {"assoc": 1.0, "id": "ENSG00000114200", "label": "BCHE"}, {"assoc": 0.0475636037, "id": "ENSG00000137968", "label": "SLC44A5"}, {"assoc": 0, "id": "ENSG00000206561", "label": "COLQ"}, {"assoc": 0, "id": "ENSG00000254647", "label": "INS"}, {"assoc": 0, "id": "ENSG00000220205", "label": "VAMP2"}], "size": 7}, {"diseases": [], "links": [{"source": "ENSG00000081138", "target": "ENSG00000113361"}, {"source": "ENSG00000081138", "target": "ENSG00000140945"}, {"source": "ENSG00000081138", "target": "ENSG00000150394"}, {"source": "ENSG00000113361", "target": "ENSG00000140945"}, {"source": "ENSG00000113361", "target": "ENSG00000150394"}, {"source": "ENSG00000140945", "target": "ENSG00000150394"}], "drugs": [], "heat": 0.18242146903125, "nodes": [{"assoc": 0.1799313336, "id": "ENSG00000081138", "label": "CDH7"}, {"assoc": 0.1874783137, "id": "ENSG00000113361", "label": "CDH6"}, {"assoc": 0.204895093525, "id": "ENSG00000140945", "label": "CDH13"}, {"assoc": 0.1573811353, "id": "ENSG00000150394", "label": "CDH8"}], "size": 4}, {"diseases": ["SCHIZOPHRENIA", "PSYCHOSIS", "BIPOLAR DISORDER", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER", "ACUTE MYELOID LEUKEMIA", "NEONATAL ABSTINENCE SYNDROME", "AUTISM", "COCAINE DEPENDENCE", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY", "LIVER DISEASE", "POST-TRAUMATIC STRESS DISORDER", "AUTISM SPECTRUM DISORDER", "ALCOHOL DEPENDENCE", "HEROIN DEPENDENCE", "FIBROMYALGIA", "CANCER", "EATING DISORDER", "HUNTINGTON DISEASE", "GAMBLING BEHAVIOUR", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "HIV INFECTION", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "LYMPHOID NEOPLASM", "BREAST CARCINOMA", "ASTHMA", "NICOTINE DEPENDENCE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN", "INSOMNIA", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "MENTAL OR BEHAVIOURAL DISORDER", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "POSTPARTUM DEPRESSION", "AMYOTROPHIC LATERAL SCLEROSIS", "SCHIZOAFFECTIVE DISORDER", "OBSESSIVE-COMPULSIVE DISORDER", "ACUTE CORONARY SYNDROME", "MIGRAINE DISORDER", "SPASTICITY", "CEREBRAL PALSY", "MYALGIA", "PAIN", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "MULTIPLE SCLEROSIS", "PARKINSON'S DISEASE", "BENIGN PROSTATIC HYPERPLASIA", "KIDNEY STONE", "PREMATURE EJACULATION", "PROSTATE CARCINOMA", "PROSTATITIS", "HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "CARDIOVASCULAR DISEASE", "CATARACT", "CARDIAC ARRHYTHMIA", "STROKE", "HYPERPLASIA", "NEUROGENIC BLADDER", "ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "SEASONAL ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS", "PREECLAMPSIA", "RENAL INSUFFICIENCY", "HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "CHRONIC KIDNEY DISEASE", "MULTIPLE SYSTEM ATROPHY"], "links": [{"source": "ENSG00000102468", "target": "ENSG00000120907"}, {"source": "ENSG00000102468", "target": "ENSG00000170214"}, {"source": "ENSG00000102468", "target": "ENSG00000171873"}, {"source": "ENSG00000120907", "target": "ENSG00000170214"}, {"source": "ENSG00000120907", "target": "ENSG00000171873"}, {"source": "ENSG00000170214", "target": "ENSG00000171873"}], "drugs": [{"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "EATING DISORDER", "stage": 3}, {"efo_term": "HUNTINGTON DISEASE", "stage": 3}, {"efo_term": "GAMBLING BEHAVIOUR", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "LYMPHOID NEOPLASM", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "VOMITING", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "OLANZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL715", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "EATING DISORDER", "HUNTINGTON DISEASE", "SCHIZOPHRENIA", "DIABETES MELLITUS", "GAMBLING BEHAVIOUR", "UNIPOLAR DEPRESSION", "CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING", "FISH-EYE DISEASE", "HIV INFECTION", "ALCOHOL DEPENDENCE", "AUTISM", "PSYCHOSIS", "VOMITING", "INSULIN RESISTANCE", "POST OPERATIVE NAUSEA AND VOMITING", "CANCER", "LYMPHOID NEOPLASM", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "AUTISM", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "AGGRESSIVE BEHAVIOR", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AGITATION", "stage": 4}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 3}, {"efo_term": "MENTAL OR BEHAVIOURAL DISORDER", "stage": 3}, {"efo_term": "TOURETTE SYNDROME", "stage": 3}, {"efo_term": "ANOREXIA NERVOSA", "stage": 3}, {"efo_term": "POSTPARTUM DEPRESSION", "stage": 3}, {"efo_term": "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 1}], "max_phase": 4, "name": "ARIPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1112", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["ALCOHOL DEPENDENCE", "ALZHEIMERS DISEASE", "ATTENTION DEFICIT HYPERACTIVITY DISORDER", "AUTISM", "BIPOLAR DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MENTAL OR BEHAVIOURAL DISORDER", "PSYCHOSIS", "TOURETTE SYNDROME", "DIABETES MELLITUS", "POST-TRAUMATIC STRESS DISORDER", "ANOREXIA NERVOSA", "AGGRESSIVE BEHAVIOR", "AGITATION", "AUTISM SPECTRUM DISORDER", "POSTPARTUM DEPRESSION", "COCAINE DEPENDENCE"]}, {"indications": [{"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "CONGESTIVE HEART FAILURE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "EPILEPSY", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL723", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HEART FAILURE", "HYPERTENSION", "PULMONARY HYPERTENSION", "CANCER", "EPILEPSY", "ATRIAL FIBRILLATION", "CONGESTIVE HEART FAILURE", "POST-TRAUMATIC STRESS DISORDER", "BREAST CARCINOMA", "CARDIOVASCULAR DISEASE", "COCAINE DEPENDENCE", "NICOTINE DEPENDENCE", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "NASAL OBSTRUCTION", "stage": 4}, {"efo_term": "GLAUCOMA", "stage": 4}, {"efo_term": "OBSTRUCTIVE LUNG DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "ALLERGIC RHINITIS", "stage": 4}, {"efo_term": "URTICARIA", "stage": 4}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 4}, {"efo_term": "ANGIOEDEMA", "stage": 4}, {"efo_term": "SINUSITIS", "stage": 4}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "SUDDEN CARDIAC ARREST", "stage": 3}, {"efo_term": "BRONCHIOLITIS", "stage": 3}], "max_phase": 4, "name": "EPINEPHRINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["ASTHMA", "NASAL OBSTRUCTION", "SUDDEN CARDIAC ARREST", "BRONCHIOLITIS", "GLAUCOMA", "OBSTRUCTIVE LUNG DISEASE", "HEMORRHAGE", "CARDIOVASCULAR DISEASE", "SEASONAL ALLERGIC RHINITIS", "ALLERGIC RHINITIS", "URTICARIA", "ANGIOEDEMA", "SINUSITIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "AUTISM", "stage": 4}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "RISPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL85", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AUTISM", "COCAINE DEPENDENCE", "DIABETES MELLITUS", "UNIPOLAR DEPRESSION", "FISH-EYE DISEASE", "INJURY"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 3}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 1}], "max_phase": 4, "name": "QUETIAPINE FUMARATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200911", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "FISH-EYE DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "MULTIPLE SCLEROSIS", "ALCOHOL DEPENDENCE"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "TOURETTE SYNDROME", "stage": 4}, {"efo_term": "CONDUCT DISORDER", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AGITATION", "stage": 3}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}], "max_phase": 4, "name": "HALOPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL54", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "PSYCHOSIS", "SCHIZOPHRENIA", "AGITATION", "POST-OPERATIVE SIGN OR SYMPTOM", "TOURETTE SYNDROME", "CONDUCT DISORDER"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "AUTISM SPECTRUM DISORDER", "stage": 3}, {"efo_term": "HEROIN DEPENDENCE", "stage": 3}, {"efo_term": "ALCOHOL DEPENDENCE", "stage": 2}, {"efo_term": "COCAINE DEPENDENCE", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "MIRTAZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL654", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION", "AUTISM SPECTRUM DISORDER", "ALCOHOL DEPENDENCE", "COCAINE DEPENDENCE", "HEROIN DEPENDENCE", "FIBROMYALGIA", "CANCER"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "NEUROPATHIC PAIN", "stage": 2}, {"efo_term": "ASTHMA", "stage": 1}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 1}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 1}], "max_phase": 4, "name": "LOXAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL831", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["ASTHMA", "NICOTINE DEPENDENCE", "PSYCHOSIS", "SCHIZOPHRENIA", "BIPOLAR DISORDER", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "NEUROPATHIC PAIN"]}, {"indications": [{"efo_term": "ORTHOSTATIC HYPOTENSION", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "HYPOTENSION", "stage": 2}, {"efo_term": "FIBROMYALGIA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "MULTIPLE SYSTEM ATROPHY", "stage": 2}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 1}], "max_phase": 4, "name": "DROXIDOPA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103827", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HYPOTENSION", "ORTHOSTATIC HYPOTENSION", "FIBROMYALGIA", "CARDIOVASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "PARKINSON'S DISEASE", "MULTIPLE SYSTEM ATROPHY"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "AUTISM", "stage": 3}, {"efo_term": "OBSESSIVE-COMPULSIVE DISORDER", "stage": 2}], "max_phase": 4, "name": "PALIPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1621", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER", "OBSESSIVE-COMPULSIVE DISORDER", "PSYCHOSIS", "AUTISM"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}, {"efo_term": "INSOMNIA", "stage": 3}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 3}], "max_phase": 4, "name": "BREXPIPRAZOLE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105760", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "UNIPOLAR DEPRESSION", "INSOMNIA", "PSYCHOSIS", "POST-TRAUMATIC STRESS DISORDER"]}, {"indications": [{"efo_term": "EYE DISEASE", "stage": 3}, {"efo_term": "RHINITIS", "stage": 3}, {"efo_term": "ROSACEA", "stage": 3}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "GRAVES OPHTHALMOPATHY", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "OXYMETAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200791", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["ALLERGIC RHINITIS", "EYE DISEASE", "ALLERGIC CONJUNCTIVITIS", "RHINITIS", "ROSACEA", "GRAVES OPHTHALMOPATHY"]}, {"indications": [{"efo_term": "SPASTICITY", "stage": 4}, {"efo_term": "CEREBRAL PALSY", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "CYCLOBENZAPRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200636", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "SPASTICITY", "CEREBRAL PALSY", "MYALGIA", "PAIN"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "KIDNEY STONE", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "PREMATURE EJACULATION", "stage": 2}, {"efo_term": "PROSTATITIS", "stage": 2}], "max_phase": 4, "name": "SILODOSIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL24778", "mechanisms": ["Alpha-1a adrenergic receptor antagonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA", "KIDNEY STONE", "PREMATURE EJACULATION", "PROSTATE CARCINOMA", "PROSTATITIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "ILOPERIDONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL14376", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "LIVER DISEASE", "POST-TRAUMATIC STRESS DISORDER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "POST-OPERATIVE SIGN OR SYMPTOM", "stage": 3}, {"efo_term": "HYPERPLASIA", "stage": 2}, {"efo_term": "NEUROGENIC BLADDER", "stage": 2}], "max_phase": 4, "name": "TAMSULOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200914", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA", "HYPERPLASIA", "POST-OPERATIVE SIGN OR SYMPTOM", "NEUROGENIC BLADDER"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "NEONATAL ABSTINENCE SYNDROME", "stage": 3}], "max_phase": 4, "name": "CHLORPROMAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL71", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "NEONATAL ABSTINENCE SYNDROME"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "AMYOTROPHIC LATERAL SCLEROSIS", "stage": 2}], "max_phase": 4, "name": "PIMOZIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1423", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "SCHIZOPHRENIA", "AMYOTROPHIC LATERAL SCLEROSIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 4}, {"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 3}], "max_phase": 4, "name": "ASENAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544974", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["BIPOLAR DISORDER", "SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "BIPOLAR DISORDER", "stage": 3}, {"efo_term": "SCHIZOPHRENIA", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}], "max_phase": 3, "name": "ITI-007", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545044", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "BIPOLAR DISORDER", "SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "CARVEDILOL PHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201167", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CLOZAPINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL42", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 1}], "max_phase": 4, "name": "THIORIDAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL479", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS", "ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}, {"efo_term": "CANCER", "stage": 2}], "max_phase": 4, "name": "HALOPERIDOL DECANOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200986", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["CANCER", "PSYCHOSIS"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "SCHIZOAFFECTIVE DISORDER", "stage": 4}], "max_phase": 4, "name": "PALIPERIDONE PALMITATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201732", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "SCHIZOAFFECTIVE DISORDER"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}, {"efo_term": "BIPOLAR DISORDER", "stage": 4}], "max_phase": 4, "name": "LURASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1615372", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA", "BIPOLAR DISORDER"]}, {"indications": [{"efo_term": "PARKINSON'S DISEASE", "stage": 4}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}], "max_phase": 4, "name": "PIMAVANSERIN TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2448613", "mechanisms": ["Serotonin 2a (5-HT2a) receptor inverse agonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PARKINSON'S DISEASE", "ALZHEIMERS DISEASE"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 4}, {"efo_term": "KIDNEY STONE", "stage": 3}], "max_phase": 4, "name": "ALFUZOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1723", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["KIDNEY STONE", "BENIGN PROSTATIC HYPERPLASIA"]}, {"indications": [{"efo_term": "CATARACT", "stage": 3}, {"efo_term": "CARDIAC ARRHYTHMIA", "stage": 1}], "max_phase": 4, "name": "PHENYLEPHRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200339", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["CATARACT", "CARDIAC ARRHYTHMIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "CHLORPROTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL908", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "VOLINANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL74355", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "DROPERIDOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1108", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "PSYCHOSIS", "stage": 4}], "max_phase": 4, "name": "THIOTHIXENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["PSYCHOSIS"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "EPLIVANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL257704", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 2}], "max_phase": 2, "name": "NELOTANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL598172", "mechanisms": ["Serotonin 2a (5-HT2a) receptor inverse agonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "ACUTE CORONARY SYNDROME", "stage": 1}], "max_phase": 1, "name": "TEMANOGREL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1084617", "mechanisms": ["Serotonin 2a (5-HT2a) receptor inverse agonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["ACUTE CORONARY SYNDROME"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 3}], "max_phase": 4, "name": "TRAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200798", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "ZIPRASIDONE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200997", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 3}], "max_phase": 4, "name": "OLANZAPINE PAMOATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201741", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}], "max_phase": 2, "name": "TEDATIOXETINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104986", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist", "Alpha-1a adrenergic receptor antagonist"], "genes": ["HTR2A", "ADRA1A"], "type": "Small molecule", "diseases": ["UNIPOLAR DEPRESSION"]}, {"indications": [{"efo_term": "INSOMNIA", "stage": 3}], "max_phase": 3, "name": "ESMIRTAZAPINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107339", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": ["INSOMNIA"]}, {"indications": [{"efo_term": "SCHIZOPHRENIA", "stage": 4}], "max_phase": 4, "name": "ARIPIPRAZOLE LAUROXIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2219425", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Unknown", "diseases": ["SCHIZOPHRENIA"]}, {"indications": [{"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "MIDODRINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200461", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["STROKE"]}, {"indications": [{"efo_term": "ASTHMA", "stage": 4}], "max_phase": 4, "name": "PHENYLEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062264", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["ASTHMA"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}], "max_phase": 4, "name": "ERGOLOID MESYLATES", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2311030", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["CARDIOVASCULAR DISEASE"]}, {"indications": [{"efo_term": "HYPERTENSION", "stage": 4}], "max_phase": 4, "name": "RAUWOLFIA SERPENTINA", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3559672", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["HYPERTENSION"]}, {"indications": [{"efo_term": "PREECLAMPSIA", "stage": 2}], "max_phase": 4, "name": "LABETALOL HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200323", "mechanisms": ["Adrenergic receptor antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["PREECLAMPSIA"]}, {"indications": [{"efo_term": "RENAL INSUFFICIENCY", "stage": 0}], "max_phase": 4, "name": "NORADRENALINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1356607", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": ["RENAL INSUFFICIENCY"]}, {"indications": [], "max_phase": 4, "name": "TRIFLUOPERAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1710", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ZIPRASIDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1712", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CHLORPROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1713", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MOLINDONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200419", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PROMAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200469", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NEFAZODONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200492", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIOTHIXENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200902", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "THIORIDAZINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200916", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TRIMIPRAMINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200948", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist", "Adrenergic receptor alpha-1 antagonist"], "genes": ["HTR2A", "ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MESORIDAZINE BESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201052", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201060", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "LOXAPINE SUCCINATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201155", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "PRUVANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1215661", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HALOPERIDOL LACTATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096643", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "VABICASERIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104991", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "IFERANSERIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107754", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "CARPHENAZINE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2358147", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Trelanserin", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3183740", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SB-773812", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545102", "mechanisms": ["Serotonin 2a (5-HT2a) receptor antagonist"], "genes": ["HTR2A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "DABUZALGRON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL257978", "mechanisms": ["Alpha-1a adrenergic receptor partial agonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYLPROPANOLAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200695", "mechanisms": ["Alpha-1a adrenergic receptor agonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DAPIPRAZOLE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201044", "mechanisms": ["Alpha-1a adrenergic receptor antagonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENYLPROPANOLAMINE POLISTIREX", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201535", "mechanisms": ["Alpha-1a adrenergic receptor agonist"], "genes": ["ADRA1A"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PRAZOSIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1558", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DOXAZOSIN MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200561", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TERAZOSIN HYDROCHLORIDE HYDRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201091", "mechanisms": ["Adrenergic receptor alpha-1 antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METHOXAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201103", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "METARAMINOL BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062262", "mechanisms": ["Adrenergic receptor alpha-1 agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOLAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1689", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "NAPHAZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1706", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TETRAHYDROZOLINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200413", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENOXYBENZAMINE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200787", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "PHENTOLAMINE MESYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200873", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ALSEROXYLON", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201454", "mechanisms": ["Adrenergic receptor alpha antagonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ERGOTAMINE TARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2062265", "mechanisms": ["Adrenergic receptor alpha agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "HYDROXYAMPHETAMINE HYDROBROMIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200705", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "DIPIVEFRIN HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200833", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MEPHENTERMINE SULFATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200996", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "EPINEPHRINE BITARTRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1256958", "mechanisms": ["Adrenergic receptor agonist"], "genes": ["ADRA1A", "ADRA1B", "ADRA1D"], "type": "Small molecule", "diseases": []}], "heat": 1.0, "nodes": [{"assoc": 1.0, "id": "ENSG00000102468", "label": "HTR2A"}, {"assoc": 1.0, "id": "ENSG00000120907", "label": "ADRA1A"}, {"assoc": 1.0, "id": "ENSG00000170214", "label": "ADRA1B"}, {"assoc": 1.0, "id": "ENSG00000171873", "label": "ADRA1D"}], "size": 4}, {"diseases": ["BASAL CELL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "PSORIASIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "SEPSIS", "BREAST CARCINOMA", "ATOPIC ECZEMA", "TYPE I DIABETES MELLITUS", "BREAST NEOPLASM", "HYPOPARATHYROIDISM", "HYPOCALCEMIA", "OSTEOPOROSIS", "PROSTATE CARCINOMA", "HYPERTENSION", "MENOPAUSE", "ACUTE KIDNEY INJURY", "HEART FAILURE", "HEPATITIS C INFECTION", "NEUROFIBROMATOSIS TYPE 1", "SICKLE CELL ANEMIA", "TIBIA FRACTURE", "TYPE II DIABETES MELLITUS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "PNEUMONIA", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "COLORECTAL ADENOCARCINOMA", "MULTIPLE SCLEROSIS", "VITAMIN D DEFICIENCY", "ABNORMAL GLUCOSE TOLERANCE", "CROHN'S DISEASE", "INFLUENZA INFECTION", "COLORECTAL ADENOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "OBESITY", "INFECTION", "COGNITIVE IMPAIRMENT", "TUBERCULOSIS", "DIABETES MELLITUS", "HYPOGONADISM", "ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "AIDS", "SKIN NEOPLASM", "METABOLIC SYNDROME", "PROSTATE ADENOCARCINOMA", "IRRITABLE BOWEL SYNDROME", "NON-ALCOHOLIC FATTY LIVER DISEASE", "ALLERGIC CONJUNCTIVITIS", "ALLERGY", "PREGNANCY", "POSTMENOPAUSAL OSTEOPOROSIS", "PARKINSON'S DISEASE", "AUTISM", "AGING", "HYPERLIPIDEMIA", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "PREMATURE BIRTH", "OPTIC NEURITIS", "MELANOMA", "RESPIRATORY TRACT INFECTION", "CARDIOVASCULAR DISEASE", "NEOPLASM", "BONE FRACTURE", "APHTHOUS ULCER", "BLADDER CARCINOMA", "INFLAMMATORY BOWEL DISEASE", "HYPERPARATHYROIDISM", "LUNG CARCINOMA", "OSTEOPENIA", "CHRONIC HEPATITIS C INFECTION", "CUTANEOUS MELANOMA", "OSTEOARTHRITIS", "ULCERATIVE COLITIS", "SARCOPENIA", "CANCER", "POLYCYSTIC OVARY SYNDROME", "RESTLESS LEGS SYNDROME", "CYSTIC FIBROSIS", "INSULIN RESISTANCE", "CUTANEOUS LUPUS ERYTHEMATOSUS", "SECONDARY HYPERPARATHYROIDISM", "IGA GLOMERULONEPHRITIS", "PROTEINURIA", "ACNE", "SYSTEMIC SCLERODERMA", "ACUTE MYELOID LEUKEMIA", "MYOCARDIAL INFARCTION", "COLITIS", "COLONIC DIVERTICULOSIS", "PROCTITIS", "NUTRITIONAL DISORDER", "BERYLLIOSIS", "LYNCH SYNDROME", "CENTRAL NERVOUS SYSTEM CANCER", "ORAL LEUKOPLAKIA", "SARCOMA", "LIVER DISEASE", "DIABETIC NEPHROPATHY", "PULMONARY HYPERTENSION", "GOUT", "BENIGN PROSTATIC HYPERPLASIA", "ALZHEIMERS DISEASE", "HEPATOCELLULAR CARCINOMA", "OVARIAN CARCINOMA", "ENDOMETRIAL NEOPLASM", "INJURY", "AMENORRHEA", "TURNER SYNDROME", "DYSPAREUNIA"], "links": [{"source": "ENSG00000111424", "target": "ENSG00000132170"}, {"source": "ENSG00000111424", "target": "ENSG00000140009"}, {"source": "ENSG00000111424", "target": "ENSG00000164749"}, {"source": "ENSG00000132170", "target": "ENSG00000140009"}, {"source": "ENSG00000132170", "target": "ENSG00000164749"}, {"source": "ENSG00000140009", "target": "ENSG00000164749"}], "drugs": [{"indications": [{"efo_term": "VITAMIN D DEFICIENCY", "stage": 4}, {"efo_term": "OSTEOPOROSIS", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "HEPATITIS C INFECTION", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "HIV INFECTION", "stage": 3}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "INFLUENZA INFECTION", "stage": 3}, {"efo_term": "COLORECTAL ADENOMA", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 3}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 3}, {"efo_term": "INFECTION", "stage": 3}, {"efo_term": "COGNITIVE IMPAIRMENT", "stage": 3}, {"efo_term": "TUBERCULOSIS", "stage": 3}, {"efo_term": "HYPOGONADISM", "stage": 3}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 3}, {"efo_term": "MELANOMA", "stage": 3}, {"efo_term": "RESPIRATORY TRACT INFECTION", "stage": 3}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 3}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "ABNORMAL GLUCOSE TOLERANCE", "stage": 2}, {"efo_term": "CROHN'S DISEASE", "stage": 2}, {"efo_term": "OBESITY", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "AIDS", "stage": 2}, {"efo_term": "METABOLIC SYNDROME", "stage": 2}, {"efo_term": "NON-ALCOHOLIC FATTY LIVER DISEASE", "stage": 2}, {"efo_term": "ALLERGIC CONJUNCTIVITIS", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "ALLERGY", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "AUTISM", "stage": 2}, {"efo_term": "AGING", "stage": 2}, {"efo_term": "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}, {"efo_term": "BONE FRACTURE", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 1}, {"efo_term": "TIBIA FRACTURE", "stage": 1}, {"efo_term": "PNEUMONIA", "stage": 1}, {"efo_term": "SKIN NEOPLASM", "stage": 1}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 1}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 1}, {"efo_term": "HYPERLIPIDEMIA", "stage": 1}, {"efo_term": "NEOPLASM", "stage": 1}, {"efo_term": "PREMATURE BIRTH", "stage": 0}], "max_phase": 4, "name": "CHOLECALCIFEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1042", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "HEART FAILURE", "HEPATITIS C INFECTION", "NEUROFIBROMATOSIS TYPE 1", "SICKLE CELL ANEMIA", "SYSTEMIC LUPUS ERYTHEMATOSUS", "TIBIA FRACTURE", "TYPE II DIABETES MELLITUS", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "PNEUMONIA", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "COLORECTAL ADENOCARCINOMA", "MULTIPLE SCLEROSIS", "VITAMIN D DEFICIENCY", "ABNORMAL GLUCOSE TOLERANCE", "CROHN'S DISEASE", "INFLUENZA INFECTION", "COLORECTAL ADENOMA", "PROSTATE CARCINOMA", "CHRONIC LYMPHOCYTIC LEUKEMIA", "OBESITY", "INFECTION", "COGNITIVE IMPAIRMENT", "TUBERCULOSIS", "DIABETES MELLITUS", "OSTEOPOROSIS", "HYPOGONADISM", "ASTHMA", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "AIDS", "SKIN NEOPLASM", "METABOLIC SYNDROME", "PROSTATE ADENOCARCINOMA", "TYPE I DIABETES MELLITUS", "IRRITABLE BOWEL SYNDROME", "NON-ALCOHOLIC FATTY LIVER DISEASE", "ALLERGIC CONJUNCTIVITIS", "ATOPIC ECZEMA", "ALLERGY", "PREGNANCY", "POSTMENOPAUSAL OSTEOPOROSIS", "PARKINSON'S DISEASE", "AUTISM", "AGING", "HYPERLIPIDEMIA", "HEREDITARY BREAST AND OVARIAN CANCER SYNDROME", "PREMATURE BIRTH", "OPTIC NEURITIS", "MELANOMA", "RESPIRATORY TRACT INFECTION", "CARDIOVASCULAR DISEASE", "NEOPLASM", "BONE FRACTURE"]}, {"indications": [{"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "APHTHOUS ULCER", "stage": 3}, {"efo_term": "VITAMIN D DEFICIENCY", "stage": 3}, {"efo_term": "BLADDER CARCINOMA", "stage": 3}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 3}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "OBESITY", "stage": 3}, {"efo_term": "CHRONIC HEPATITIS C INFECTION", "stage": 3}, {"efo_term": "CUTANEOUS MELANOMA", "stage": 3}, {"efo_term": "NON-ALCOHOLIC FATTY LIVER DISEASE", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "TUBERCULOSIS", "stage": 3}, {"efo_term": "CANCER", "stage": 3}, {"efo_term": "PREGNANCY", "stage": 3}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "HEART FAILURE", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "RESTLESS LEGS SYNDROME", "stage": 2}, {"efo_term": "OPTIC NEURITIS", "stage": 2}, {"efo_term": "CYSTIC FIBROSIS", "stage": 2}, {"efo_term": "INSULIN RESISTANCE", "stage": 2}, {"efo_term": "CUTANEOUS LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 1}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 1}, {"efo_term": "INFLAMMATORY BOWEL DISEASE", "stage": 1}, {"efo_term": "HYPERPARATHYROIDISM", "stage": 1}, {"efo_term": "LUNG CARCINOMA", "stage": 1}, {"efo_term": "ULCERATIVE COLITIS", "stage": 1}, {"efo_term": "SARCOPENIA", "stage": 1}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 1}, {"efo_term": "OSTEOPENIA", "stage": 0}], "max_phase": 4, "name": "ERGOCALCIFEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1536", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE", "BREAST NEOPLASM", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "APHTHOUS ULCER", "VITAMIN D DEFICIENCY", "BLADDER CARCINOMA", "TYPE I DIABETES MELLITUS", "BREAST CARCINOMA", "COLORECTAL ADENOCARCINOMA", "TYPE II DIABETES MELLITUS", "INFLAMMATORY BOWEL DISEASE", "MULTIPLE SCLEROSIS", "HYPERPARATHYROIDISM", "LUNG CARCINOMA", "OSTEOPENIA", "PROSTATE ADENOCARCINOMA", "OBESITY", "CHRONIC HEPATITIS C INFECTION", "CUTANEOUS MELANOMA", "HIV INFECTION", "NON-ALCOHOLIC FATTY LIVER DISEASE", "HEART FAILURE", "OSTEOARTHRITIS", "SICKLE CELL ANEMIA", "ULCERATIVE COLITIS", "SARCOPENIA", "TUBERCULOSIS", "CANCER", "POLYCYSTIC OVARY SYNDROME", "PREGNANCY", "RESTLESS LEGS SYNDROME", "OPTIC NEURITIS", "CYSTIC FIBROSIS", "INSULIN RESISTANCE", "CUTANEOUS LUPUS ERYTHEMATOSUS", "ASTHMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "HYPOPARATHYROIDISM", "stage": 4}, {"efo_term": "HYPOCALCEMIA", "stage": 4}, {"efo_term": "OSTEOPOROSIS", "stage": 3}, {"efo_term": "BASAL CELL CARCINOMA", "stage": 2}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "ATOPIC ECZEMA", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}, {"efo_term": "MENOPAUSE", "stage": 1}], "max_phase": 4, "name": "CALCITRIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL846", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["BASAL CELL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "PSORIASIS", "SYSTEMIC LUPUS ERYTHEMATOSUS", "SEPSIS", "BREAST CARCINOMA", "ATOPIC ECZEMA", "TYPE I DIABETES MELLITUS", "BREAST NEOPLASM", "HYPOPARATHYROIDISM", "HYPOCALCEMIA", "OSTEOPOROSIS", "PROSTATE CARCINOMA", "HYPERTENSION", "MENOPAUSE", "ACUTE KIDNEY INJURY"]}, {"indications": [{"efo_term": "ULCERATIVE COLITIS", "stage": 4}, {"efo_term": "CROHN'S DISEASE", "stage": 3}, {"efo_term": "PROCTITIS", "stage": 3}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 3}, {"efo_term": "COLITIS", "stage": 2}, {"efo_term": "COLONIC DIVERTICULOSIS", "stage": 2}, {"efo_term": "COLORECTAL ADENOMA", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "LYNCH SYNDROME", "stage": 2}, {"efo_term": "NUTRITIONAL DISORDER", "stage": 1}, {"efo_term": "BERYLLIOSIS", "stage": 1}], "max_phase": 4, "name": "MESALAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL704", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": ["COLITIS", "COLONIC DIVERTICULOSIS", "CROHN'S DISEASE", "PROCTITIS", "ULCERATIVE COLITIS", "IRRITABLE BOWEL SYNDROME", "NUTRITIONAL DISORDER", "COLORECTAL ADENOMA", "BERYLLIOSIS", "COLORECTAL ADENOCARCINOMA", "LYNCH SYNDROME"]}, {"indications": [{"efo_term": "CANCER", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "BREAST NEOPLASM", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "OVARIAN CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}], "max_phase": 4, "name": "FULVESTRANT", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1358", "mechanisms": ["Estrogen receptor antagonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA", "PROSTATE CARCINOMA", "CANCER", "OVARIAN CARCINOMA", "BREAST NEOPLASM", "NEOPLASM", "PROSTATE ADENOCARCINOMA", "ENDOMETRIAL NEOPLASM", "PULMONARY HYPERTENSION"]}, {"indications": [{"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 4}, {"efo_term": "SECONDARY HYPERPARATHYROIDISM", "stage": 4}, {"efo_term": "IGA GLOMERULONEPHRITIS", "stage": 3}, {"efo_term": "PROTEINURIA", "stage": 3}, {"efo_term": "HYPERPARATHYROIDISM", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}, {"efo_term": "ALLERGY", "stage": 2}], "max_phase": 4, "name": "PARICALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200622", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["CHRONIC KIDNEY DISEASE", "IGA GLOMERULONEPHRITIS", "PROTEINURIA", "TYPE II DIABETES MELLITUS", "SECONDARY HYPERPARATHYROIDISM", "HYPERPARATHYROIDISM", "ALLERGY"]}, {"indications": [{"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 4}, {"efo_term": "AMENORRHEA", "stage": 3}, {"efo_term": "TURNER SYNDROME", "stage": 3}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "MENOPAUSE", "stage": 1}], "max_phase": 4, "name": "ESTROGENS, CONJUGATED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201649", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["PROSTATE CARCINOMA", "MENOPAUSE", "PARKINSON'S DISEASE", "INJURY", "AMENORRHEA", "TURNER SYNDROME", "POSTMENOPAUSAL OSTEOPOROSIS"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 2}, {"efo_term": "ORAL LEUKOPLAKIA", "stage": 2}, {"efo_term": "SARCOMA", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 1}], "max_phase": 4, "name": "ROSIGLITAZONE MALEATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL843", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": ["HIV INFECTION", "TYPE II DIABETES MELLITUS", "CENTRAL NERVOUS SYSTEM CANCER", "ORAL LEUKOPLAKIA", "SARCOMA"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 4}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 2}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 2}, {"efo_term": "ORAL LEUKOPLAKIA", "stage": 2}, {"efo_term": "NON-ALCOHOLIC FATTY LIVER DISEASE", "stage": 1}], "max_phase": 4, "name": "PIOGLITAZONE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1715", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": ["NON-ALCOHOLIC FATTY LIVER DISEASE", "TYPE II DIABETES MELLITUS", "CHRONIC KIDNEY DISEASE", "NON-SMALL CELL LUNG CARCINOMA", "ORAL LEUKOPLAKIA"]}, {"indications": [{"efo_term": "DIABETIC NEPHROPATHY", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "CANCER", "stage": 1}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "BARDOXOLONE METHYL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1762621", "mechanisms": ["Peroxisome proliferator-activated receptor gamma antagonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": ["CANCER", "LIVER DISEASE", "DIABETIC NEPHROPATHY", "PULMONARY HYPERTENSION"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 2}, {"efo_term": "MENOPAUSE", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}, {"efo_term": "BREAST CARCINOMA", "stage": 0}], "max_phase": 2, "name": "EQUOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL198877", "mechanisms": ["Estrogen receptor beta agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA", "MENOPAUSE", "ALZHEIMERS DISEASE", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 4}, {"efo_term": "ACNE", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 1}], "max_phase": 4, "name": "CALCIPOTRIENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200666", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS", "ACNE", "SYSTEMIC SCLERODERMA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 1}], "max_phase": 4, "name": "DOXERCALCIFEROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200810", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS", "NEOPLASM", "PROSTATE CARCINOMA"]}, {"indications": [{"efo_term": "SECONDARY HYPERPARATHYROIDISM", "stage": 2}, {"efo_term": "OSTEOPOROSIS", "stage": 2}], "max_phase": 2, "name": "DP001", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL605525", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["SECONDARY HYPERPARATHYROIDISM", "OSTEOPOROSIS"]}, {"indications": [{"efo_term": "MYOCARDIAL INFARCTION", "stage": 3}, {"efo_term": "ACUTE KIDNEY INJURY", "stage": 2}], "max_phase": 4, "name": "CALCIFEDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3544909", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["MYOCARDIAL INFARCTION", "ACUTE KIDNEY INJURY"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}, {"efo_term": "GOUT", "stage": 2}], "max_phase": 2, "name": "ARHALOFENATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103824", "mechanisms": ["Peroxisome proliferator-activated receptor gamma modulator"], "genes": ["PPARG"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS", "GOUT"]}, {"indications": [{"efo_term": "POSTMENOPAUSAL OSTEOPOROSIS", "stage": 4}, {"efo_term": "OSTEOPOROSIS", "stage": 3}], "max_phase": 4, "name": "BAZEDOXIFENE ACETATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2106615", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["OSTEOPOROSIS", "POSTMENOPAUSAL OSTEOPOROSIS"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 2}], "max_phase": 2, "name": "BECOCALCIDIOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104955", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "ACUTE MYELOID LEUKEMIA", "stage": 2}], "max_phase": 2, "name": "INECALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105107", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["ACUTE MYELOID LEUKEMIA"]}, {"indications": [{"efo_term": "PSORIASIS", "stage": 3}], "max_phase": 3, "name": "PEFCALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3137307", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": ["PSORIASIS"]}, {"indications": [{"efo_term": "DIABETES MELLITUS", "stage": 4}], "max_phase": 4, "name": "TROGLITAZONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL408", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": ["DIABETES MELLITUS"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}], "max_phase": 2, "name": "MK-0533", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL490029", "mechanisms": ["Peroxisome proliferator-activated receptor gamma modulator"], "genes": ["PPARG"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}], "max_phase": 3, "name": "ALEGLITAZAR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL519504", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}], "max_phase": 3, "name": "BALAGLITAZONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103991", "mechanisms": ["Peroxisome proliferator-activated receptor gamma partial agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}], "max_phase": 3, "name": "RIVOGLITAZONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104753", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "TYPE II DIABETES MELLITUS", "stage": 2}], "max_phase": 2, "name": "MBX-2044", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545020", "mechanisms": ["Peroxisome proliferator-activated receptor gamma modulator"], "genes": ["PPARG"], "type": "Small molecule", "diseases": ["TYPE II DIABETES MELLITUS"]}, {"indications": [{"efo_term": "BENIGN PROSTATIC HYPERPLASIA", "stage": 2}], "max_phase": 2, "name": "ERTEBEREL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL278703", "mechanisms": ["Estrogen receptor beta agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["BENIGN PROSTATIC HYPERPLASIA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}], "max_phase": 4, "name": "ESTRAMUSTINE PHOSPHATE SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200721", "mechanisms": ["Estrogen receptor beta "], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "HEPATOCELLULAR CARCINOMA", "stage": 3}], "max_phase": 4, "name": "CHLOROTRIANISENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200761", "mechanisms": ["Estrogen receptor beta modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["HEPATOCELLULAR CARCINOMA"]}, {"indications": [{"efo_term": "NEOPLASM", "stage": 4}], "max_phase": 4, "name": "DIETHYLSTILBESTROL DIPHOSPHATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200598", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["NEOPLASM"]}, {"indications": [{"efo_term": "BREAST NEOPLASM", "stage": 2}], "max_phase": 4, "name": "TOREMIFENE CITRATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200675", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["BREAST NEOPLASM"]}, {"indications": [{"efo_term": "MENOPAUSE", "stage": 2}], "max_phase": 4, "name": "ESTROGENS, ESTERIFIED", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201468", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["MENOPAUSE"]}, {"indications": [{"efo_term": "DYSPAREUNIA", "stage": 4}], "max_phase": 4, "name": "OSPEMIFENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105395", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": ["DYSPAREUNIA"]}, {"indications": [], "max_phase": 1, "name": "ILX23-7553", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL284121", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "SEOCALCITOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1908376", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "LUNACALCIPOL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105705", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Elocalcitol", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545094", "mechanisms": ["Vitamin D receptor agonist"], "genes": ["VDR"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "TESAGLITAZAR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL282686", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ETALOCIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL329123", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NETOGLITAZONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL93747", "mechanisms": ["Peroxisome proliferator-activated receptor gamma modulator"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FARGLITAZAR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL107367", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "NAVEGLITAZAR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL181954", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "MURAGLITAZAR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL186179", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "IMIGLITAZAR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL592054", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BALSALAZIDE DISODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200760", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OLSALAZINE SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201013", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "INT131", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1236924", "mechanisms": ["Peroxisome proliferator-activated receptor gamma modulator"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "DB959", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545176", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CLX-0921", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545240", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "OMS405", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545277", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "ATx08-001", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545278", "mechanisms": ["Peroxisome proliferator-activated receptor gamma modulator"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "Efatutazone hydrochloride", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545279", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "AVE0847", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545295", "mechanisms": ["Peroxisome proliferator-activated receptor gamma agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "INDEGLITAZAR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1232583", "mechanisms": ["Peroxisome proliferator-activated receptor agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "SODELGLITAZAR", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2104984", "mechanisms": ["Peroxisome proliferator-activated receptor agonist"], "genes": ["PPARG"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "RALOXIFENE HYDROCHLORIDE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1116", "mechanisms": ["Estrogen receptor beta modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "PRINABEREL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL450940", "mechanisms": ["Estrogen receptor beta agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "CR 1447", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545092", "mechanisms": ["Estrogen receptor beta agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "MF101", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545411", "mechanisms": ["Estrogen receptor beta agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "IDOXIFENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6318", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "DROLOXIFENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL487", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "AFIMOXIFENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL10041", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 3, "name": "ACOLBIFENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL68055", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "QUINESTROL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201165", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "ESTROGENS, CONJUGATED SYNTHETIC A", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201466", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "SYNTHETIC CONJUGATED ESTROGENS, B", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201467", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "FISPEMIFENE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2107341", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "MK-6913", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545274", "mechanisms": ["Estrogen receptor agonist"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 1, "name": "CHF4227", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545355", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 2, "name": "LY2245461", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL3545389", "mechanisms": ["Estrogen receptor modulator"], "genes": ["ESR2"], "type": "Small molecule", "diseases": []}], "heat": 0.7070842115027499, "nodes": [{"assoc": 0.708071836294, "id": "ENSG00000111424", "label": "VDR"}, {"assoc": 1.0, "id": "ENSG00000132170", "label": "PPARG"}, {"assoc": 0.838345009717, "id": "ENSG00000140009", "label": "ESR2"}, {"assoc": 0.28192, "id": "ENSG00000164749", "label": "HNF4G"}], "size": 4}, {"diseases": [], "links": [{"source": "ENSG00000034053", "target": "ENSG00000179915"}, {"source": "ENSG00000122584", "target": "ENSG00000179915"}], "drugs": [], "heat": 0.13346702198133334, "nodes": [{"assoc": 0.058978534144, "id": "ENSG00000034053", "label": "APBA2"}, {"assoc": 0.1698970004, "id": "ENSG00000122584", "label": "NXPH1"}, {"assoc": 0.1715255314, "id": "ENSG00000179915", "label": "NRXN1"}], "size": 3}, {"diseases": ["RHEUMATIC DISEASE", "OSTEOARTHRITIS", "PAIN", "HIV INFECTION", "DYSMENORRHEA", "OSTEOARTHRITIS, HIP", "RHEUMATOID ARTHRITIS", "TUBERCULOSIS", "ANKYLOSING SPONDYLITIS", "OSTEOARTHRITIS, KNEE", "BREAST CARCINOMA", "CHRONIC CHILDHOOD ARTHRITIS", "LUNG CARCINOMA", "TONSILLITIS", "CENTRAL NERVOUS SYSTEM CANCER", "FAMILIAL ADENOMATOUS POLYPOSIS", "PREECLAMPSIA", "COLORECTAL ADENOCARCINOMA", "GOUT", "SCHIZOPHRENIA", "NON-SMALL CELL LUNG CARCINOMA", "MOUTH NEOPLASM", "OBESITY", "BLADDER CARCINOMA", "PROSTATE CARCINOMA", "NEOPLASM", "CERVICAL ADENOCARCINOMA", "NASOPHARYNGEAL NEOPLASM", "HYPERTENSION", "LYMPHANGIOLEIOMYOMATOSIS", "COLORECTAL ADENOMA", "UNIPOLAR DEPRESSION", "NICOTINE DEPENDENCE", "INFLAMMATION", "PROSTATE ADENOCARCINOMA", "HEMORRHAGE", "POLYP", "FISH-EYE DISEASE", "PANCREATITIS", "PANCREATIC CARCINOMA", "DIGESTIVE SYSTEM DISEASE", "PREMATURE BIRTH", "EYE INFLAMMATION", "ARTHRALGIA", "PATENT DUCTUS ARTERIOSUS", "MYALGIA", "CARDIOVASCULAR DISEASE", "ASTHMA", "RENAL COLIC", "NEUROPATHY", "ATRIAL FIBRILLATION", "BRAIN INFARCTION", "CORONARY ARTERY DISEASE", "DUODENAL ULCER", "FEVER", "PEPTIC ULCER", "PERIPHERAL ARTERIAL DISEASE", "TYPE II DIABETES MELLITUS", "INFECTIOUS MENINGITIS", "INFERTILITY", "MIGRAINE DISORDER", "STROKE", "SEPSIS", "SQUAMOUS CELL CARCINOMA", "PSYCHOSIS", "HEART FAILURE", "PULMONARY HYPERTENSION", "ACUTE LUNG INJURY", "GLIOBLASTOMA MULTIFORME", "HIV-1 INFECTION", "SICKLE CELL ANEMIA", "SKIN ULCER", "ATHEROSCLEROSIS", "BIPOLAR DISORDER", "VENOUS THROMBOEMBOLISM", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME", "RECURRENT THROMBOPHLEBITIS", "BREAST NEOPLASM", "OSTEOMYELITIS", "ESOPHAGEAL CARCINOMA", "PNEUMONIA", "CHRONIC KIDNEY DISEASE", "ISCHEMIA", "VENOUS THROMBOSIS", "DIABETES MELLITUS", "HYPERTROPHIC CARDIOMYOPATHY", "POLYCYTHEMIA VERA", "CORONARY HEART DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SEASONAL ALLERGIC RHINITIS", "BARRETT'S ESOPHAGUS", "VASCULAR DISEASE", "MYOCARDIAL INFARCTION", "HABITUAL ABORTION", "LYNCH SYNDROME", "PREGNANCY", "RETINAL VEIN OCCLUSION", "DIABETIC FOOT", "CEREBRAL ISCHEMIA", "ALZHEIMERS DISEASE", "OBSTRUCTIVE SLEEP APNEA", "ALLERGIC RHINITIS", "BRONCHOPULMONARY DYSPLASIA", "EMPHYSEMA", "BONE FRACTURE", "INFECTION", "VAGINAL INFLAMMATION", "DUCHENNE MUSCULAR DYSTROPHY", "COMMON COLD", "SPONDYLOARTHROPATHY", "BRAIN DISEASE", "RETINOPATHY OF PREMATURITY", "PERIODONTITIS", "CEREBRAL PALSY", "ARTHRITIS", "CLEFT PALATE", "INFLUENZA INFECTION", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "INJURY", "ABDOMINAL PAIN", "BACTERIAL MENINGITIS", "GLAUCOMA", "PULPITIS", "TYPE I DIABETES MELLITUS", "POST OPERATIVE NAUSEA AND VOMITING", "BASAL CELL CARCINOMA", "DIABETIC RETINOPATHY", "PULMONARY EMBOLISM", "COLITIS", "COLONIC DIVERTICULOSIS", "CROHN'S DISEASE", "PROCTITIS", "ULCERATIVE COLITIS", "IRRITABLE BOWEL SYNDROME", "NUTRITIONAL DISORDER", "BERYLLIOSIS", "CATARACT", "TIBIAL MUSCULAR DYSTROPHY", "PLEURAL EFFUSION", "GASTRIC ULCER", "MACULAR EDEMA", "ACTINIC KERATOSIS", "MUSCULAR DISEASE", "SKIN NEOPLASM", "TENDINOPATHY", "FROZEN SHOULDER", "LIVER DISEASE"], "links": [{"source": "ENSG00000059377", "target": "ENSG00000073756"}, {"source": "ENSG00000059377", "target": "ENSG00000095303"}], "drugs": [{"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "STROKE", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "RECURRENT THROMBOPHLEBITIS", "stage": 4}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 3}, {"efo_term": "BRAIN INFARCTION", "stage": 3}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 3}, {"efo_term": "PEPTIC ULCER", "stage": 3}, {"efo_term": "PERIPHERAL ARTERIAL DISEASE", "stage": 3}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "PREECLAMPSIA", "stage": 3}, {"efo_term": "SQUAMOUS CELL CARCINOMA", "stage": 3}, {"efo_term": "HEART FAILURE", "stage": 3}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "SKIN ULCER", "stage": 3}, {"efo_term": "ATHEROSCLEROSIS", "stage": 3}, {"efo_term": "ESOPHAGEAL CARCINOMA", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "VENOUS THROMBOSIS", "stage": 3}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "DIABETES MELLITUS", "stage": 3}, {"efo_term": "HYPERTROPHIC CARDIOMYOPATHY", "stage": 3}, {"efo_term": "CORONARY HEART DISEASE", "stage": 3}, {"efo_term": "SEASONAL ALLERGIC RHINITIS", "stage": 3}, {"efo_term": "VASCULAR DISEASE", "stage": 3}, {"efo_term": "HABITUAL ABORTION", "stage": 3}, {"efo_term": "LYNCH SYNDROME", "stage": 3}, {"efo_term": "RETINAL VEIN OCCLUSION", "stage": 3}, {"efo_term": "DIABETIC FOOT", "stage": 3}, {"efo_term": "CEREBRAL ISCHEMIA", "stage": 3}, {"efo_term": "DUODENAL ULCER", "stage": 2}, {"efo_term": "INFECTIOUS MENINGITIS", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "ACUTE LUNG INJURY", "stage": 2}, {"efo_term": "GLIOBLASTOMA MULTIFORME", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "HIV-1 INFECTION", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "VENOUS THROMBOEMBOLISM", "stage": 2}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "ACUTE RESPIRATORY DISTRESS SYNDROME", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "OSTEOMYELITIS", "stage": 2}, {"efo_term": "PNEUMONIA", "stage": 2}, {"efo_term": "ISCHEMIA", "stage": 2}, {"efo_term": "POLYCYTHEMIA VERA", "stage": 2}, {"efo_term": "NEOPLASM", "stage": 2}, {"efo_term": "POST-TRAUMATIC STRESS DISORDER", "stage": 2}, {"efo_term": "BARRETT'S ESOPHAGUS", "stage": 2}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 2}, {"efo_term": "PREGNANCY", "stage": 2}, {"efo_term": "COLORECTAL ADENOMA", "stage": 2}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 2}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 1}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 1}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 1}, {"efo_term": "PSYCHOSIS", "stage": 0}], "max_phase": 4, "name": "ASPIRIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL25", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["ATRIAL FIBRILLATION", "BRAIN INFARCTION", "CORONARY ARTERY DISEASE", "DUODENAL ULCER", "FEVER", "PEPTIC ULCER", "PERIPHERAL ARTERIAL DISEASE", "TYPE II DIABETES MELLITUS", "INFECTIOUS MENINGITIS", "INFERTILITY", "MIGRAINE DISORDER", "STROKE", "PAIN", "PREECLAMPSIA", "SEPSIS", "SQUAMOUS CELL CARCINOMA", "CARDIOVASCULAR DISEASE", "PSYCHOSIS", "BREAST CARCINOMA", "HEART FAILURE", "PULMONARY HYPERTENSION", "ACUTE LUNG INJURY", "COLORECTAL ADENOCARCINOMA", "GLIOBLASTOMA MULTIFORME", "HIV INFECTION", "HIV-1 INFECTION", "SICKLE CELL ANEMIA", "SKIN ULCER", "ATHEROSCLEROSIS", "BIPOLAR DISORDER", "VENOUS THROMBOEMBOLISM", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "ACUTE RESPIRATORY DISTRESS SYNDROME", "RECURRENT THROMBOPHLEBITIS", "BREAST NEOPLASM", "OSTEOMYELITIS", "ESOPHAGEAL CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA", "PNEUMONIA", "CHRONIC KIDNEY DISEASE", "ISCHEMIA", "VENOUS THROMBOSIS", "ASTHMA", "DIABETES MELLITUS", "HYPERTROPHIC CARDIOMYOPATHY", "POLYCYTHEMIA VERA", "NEOPLASM", "CORONARY HEART DISEASE", "POST-TRAUMATIC STRESS DISORDER", "SEASONAL ALLERGIC RHINITIS", "BARRETT'S ESOPHAGUS", "VASCULAR DISEASE", "MYOCARDIAL INFARCTION", "HABITUAL ABORTION", "DIGESTIVE SYSTEM DISEASE", "LYNCH SYNDROME", "PREGNANCY", "RETINAL VEIN OCCLUSION", "DIABETIC FOOT", "COLORECTAL ADENOMA", "CEREBRAL ISCHEMIA", "NICOTINE DEPENDENCE"]}, {"indications": [{"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "FAMILIAL ADENOMATOUS POLYPOSIS", "stage": 4}, {"efo_term": "NEOPLASM", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "DYSMENORRHEA", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "GOUT", "stage": 3}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 3}, {"efo_term": "NASOPHARYNGEAL NEOPLASM", "stage": 3}, {"efo_term": "HYPERTENSION", "stage": 3}, {"efo_term": "COLORECTAL ADENOMA", "stage": 3}, {"efo_term": "NICOTINE DEPENDENCE", "stage": 3}, {"efo_term": "LUNG CARCINOMA", "stage": 2}, {"efo_term": "TONSILLITIS", "stage": 2}, {"efo_term": "CENTRAL NERVOUS SYSTEM CANCER", "stage": 2}, {"efo_term": "PREECLAMPSIA", "stage": 2}, {"efo_term": "SCHIZOPHRENIA", "stage": 2}, {"efo_term": "BLADDER CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "LYMPHANGIOLEIOMYOMATOSIS", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "MOUTH NEOPLASM", "stage": 1}, {"efo_term": "CERVICAL ADENOCARCINOMA", "stage": 1}, {"efo_term": "INFLAMMATION", "stage": 1}, {"efo_term": "OBESITY", "stage": 0}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 0}], "max_phase": 4, "name": "CELECOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL118", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["ANKYLOSING SPONDYLITIS", "BREAST CARCINOMA", "CHRONIC CHILDHOOD ARTHRITIS", "LUNG CARCINOMA", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "RHEUMATOID ARTHRITIS", "TONSILLITIS", "CENTRAL NERVOUS SYSTEM CANCER", "FAMILIAL ADENOMATOUS POLYPOSIS", "PREECLAMPSIA", "COLORECTAL ADENOCARCINOMA", "GOUT", "SCHIZOPHRENIA", "NON-SMALL CELL LUNG CARCINOMA", "MOUTH NEOPLASM", "OBESITY", "BLADDER CARCINOMA", "PROSTATE CARCINOMA", "NEOPLASM", "RHEUMATIC DISEASE", "DYSMENORRHEA", "CERVICAL ADENOCARCINOMA", "NASOPHARYNGEAL NEOPLASM", "HYPERTENSION", "LYMPHANGIOLEIOMYOMATOSIS", "COLORECTAL ADENOMA", "UNIPOLAR DEPRESSION", "NICOTINE DEPENDENCE", "INFLAMMATION", "PROSTATE ADENOCARCINOMA"]}, {"indications": [{"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "VAGINAL INFLAMMATION", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "FEVER", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "OBSTRUCTIVE SLEEP APNEA", "stage": 3}, {"efo_term": "BONE FRACTURE", "stage": 3}, {"efo_term": "DYSMENORRHEA", "stage": 3}, {"efo_term": "INFECTION", "stage": 3}, {"efo_term": "PEPTIC ULCER", "stage": 3}, {"efo_term": "COMMON COLD", "stage": 3}, {"efo_term": "CEREBRAL PALSY", "stage": 3}, {"efo_term": "BRONCHOPULMONARY DYSPLASIA", "stage": 2}, {"efo_term": "EMPHYSEMA", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "SPONDYLOARTHROPATHY", "stage": 2}, {"efo_term": "BRAIN DISEASE", "stage": 2}, {"efo_term": "HEMORRHAGE", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 2}, {"efo_term": "PREGNANCY", "stage": 2}, {"efo_term": "RETINOPATHY OF PREMATURITY", "stage": 2}, {"efo_term": "TUBERCULOSIS", "stage": 2}, {"efo_term": "PERIODONTITIS", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 1}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 1}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}, {"efo_term": "DUCHENNE MUSCULAR DYSTROPHY", "stage": 1}], "max_phase": 4, "name": "IBUPROFEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL521", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["FEVER", "MYALGIA", "OSTEOARTHRITIS", "PAIN", "PATENT DUCTUS ARTERIOSUS", "ALZHEIMERS DISEASE", "OBSTRUCTIVE SLEEP APNEA", "OSTEOARTHRITIS, KNEE", "ALLERGIC RHINITIS", "BRONCHOPULMONARY DYSPLASIA", "EMPHYSEMA", "ARTHRALGIA", "BONE FRACTURE", "DYSMENORRHEA", "HYPERTENSION", "INFECTION", "VAGINAL INFLAMMATION", "DUCHENNE MUSCULAR DYSTROPHY", "PEPTIC ULCER", "COMMON COLD", "RHEUMATIC DISEASE", "CARDIOVASCULAR DISEASE", "SPONDYLOARTHROPATHY", "BRAIN DISEASE", "HEMORRHAGE", "UNIPOLAR DEPRESSION", "PREGNANCY", "RETINOPATHY OF PREMATURITY", "TUBERCULOSIS", "PERIODONTITIS", "CEREBRAL PALSY"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "MIGRAINE DISORDER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "ARTHRITIS", "stage": 4}, {"efo_term": "INFLUENZA INFECTION", "stage": 4}, {"efo_term": "DYSMENORRHEA", "stage": 4}, {"efo_term": "COMMON COLD", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "ABDOMINAL PAIN", "stage": 3}, {"efo_term": "BACTERIAL MENINGITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 2}, {"efo_term": "CLEFT PALATE", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "HYPERTENSION", "stage": 2}, {"efo_term": "BORDERLINE PERSONALITY DISORDER SYMPTOM", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "INJURY", "stage": 2}, {"efo_term": "HEMORRHAGE", "stage": 2}, {"efo_term": "CERVICAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "TONSILLITIS", "stage": 2}, {"efo_term": "BRAIN DISEASE", "stage": 2}, {"efo_term": "PULPITIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "RENAL COLIC", "stage": 2}, {"efo_term": "GLAUCOMA", "stage": 0}], "max_phase": 4, "name": "ACETAMINOPHEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL112", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["FEVER", "MIGRAINE DISORDER", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "DIGESTIVE SYSTEM DISEASE", "ARTHRITIS", "CLEFT PALATE", "PATENT DUCTUS ARTERIOSUS", "HYPERTENSION", "INFLUENZA INFECTION", "BORDERLINE PERSONALITY DISORDER SYMPTOM", "SEPSIS", "INJURY", "ABDOMINAL PAIN", "DYSMENORRHEA", "COMMON COLD", "HEMORRHAGE", "BACTERIAL MENINGITIS", "CERVICAL ADENOCARCINOMA", "GLAUCOMA", "TONSILLITIS", "BRAIN DISEASE", "PULPITIS", "TYPE I DIABETES MELLITUS", "OSTEOARTHRITIS, HIP", "RENAL COLIC"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "VAGINAL INFLAMMATION", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "GASTRIC ULCER", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "CHRONIC CHILDHOOD ARTHRITIS", "stage": 3}, {"efo_term": "PEPTIC ULCER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "DUODENAL ULCER", "stage": 2}, {"efo_term": "PLEURAL EFFUSION", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "TIBIAL MUSCULAR DYSTROPHY", "stage": 1}, {"efo_term": "LYNCH SYNDROME", "stage": 1}], "max_phase": 4, "name": "NAPROXEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL154", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS", "PAIN", "ARTHRALGIA", "RHEUMATOID ARTHRITIS", "TIBIAL MUSCULAR DYSTROPHY", "LYNCH SYNDROME", "VAGINAL INFLAMMATION", "ANKYLOSING SPONDYLITIS", "MYALGIA", "OSTEOARTHRITIS, KNEE", "CHRONIC CHILDHOOD ARTHRITIS", "PEPTIC ULCER", "RHEUMATIC DISEASE", "DUODENAL ULCER", "PLEURAL EFFUSION", "ALZHEIMERS DISEASE", "GASTRIC ULCER", "OSTEOARTHRITIS, HIP"]}, {"indications": [{"efo_term": "EYE INFLAMMATION", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "GOUT", "stage": 3}, {"efo_term": "PREMATURE BIRTH", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "RENAL COLIC", "stage": 3}, {"efo_term": "PANCREATITIS", "stage": 2}, {"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 2}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}, {"efo_term": "DIGESTIVE SYSTEM DISEASE", "stage": 0}], "max_phase": 4, "name": "INDOMETHACIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL6", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["DIGESTIVE SYSTEM DISEASE", "GOUT", "PANCREATITIS", "PREMATURE BIRTH", "ANKYLOSING SPONDYLITIS", "EYE INFLAMMATION", "ARTHRALGIA", "PAIN", "PATENT DUCTUS ARTERIOSUS", "FISH-EYE DISEASE", "MYALGIA", "CARDIOVASCULAR DISEASE", "RHEUMATIC DISEASE", "ASTHMA", "RENAL COLIC"]}, {"indications": [{"efo_term": "EYE INFLAMMATION", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "INFERTILITY", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "BASAL CELL CARCINOMA", "stage": 2}, {"efo_term": "PULMONARY EMBOLISM", "stage": 2}, {"efo_term": "UNIPOLAR DEPRESSION", "stage": 1}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 1}], "max_phase": 4, "name": "DICLOFENAC", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL139", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["EYE INFLAMMATION", "OSTEOARTHRITIS", "OSTEOARTHRITIS, KNEE", "PAIN", "ANKYLOSING SPONDYLITIS", "BASAL CELL CARCINOMA", "RHEUMATOID ARTHRITIS", "UNIPOLAR DEPRESSION", "ARTHRALGIA", "DIABETIC RETINOPATHY", "MYALGIA", "PULMONARY EMBOLISM", "RHEUMATIC DISEASE", "INFERTILITY", "OSTEOARTHRITIS, HIP"]}, {"indications": [{"efo_term": "ULCERATIVE COLITIS", "stage": 4}, {"efo_term": "CROHN'S DISEASE", "stage": 3}, {"efo_term": "PROCTITIS", "stage": 3}, {"efo_term": "IRRITABLE BOWEL SYNDROME", "stage": 3}, {"efo_term": "COLITIS", "stage": 2}, {"efo_term": "COLONIC DIVERTICULOSIS", "stage": 2}, {"efo_term": "COLORECTAL ADENOMA", "stage": 2}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}, {"efo_term": "LYNCH SYNDROME", "stage": 2}, {"efo_term": "NUTRITIONAL DISORDER", "stage": 1}, {"efo_term": "BERYLLIOSIS", "stage": 1}], "max_phase": 4, "name": "MESALAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL704", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["COLITIS", "COLONIC DIVERTICULOSIS", "CROHN'S DISEASE", "PROCTITIS", "ULCERATIVE COLITIS", "IRRITABLE BOWEL SYNDROME", "NUTRITIONAL DISORDER", "COLORECTAL ADENOMA", "BERYLLIOSIS", "COLORECTAL ADENOCARCINOMA", "LYNCH SYNDROME"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "DYSMENORRHEA", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "TUBERCULOSIS", "stage": 1}], "max_phase": 4, "name": "ETORICOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL416146", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "OSTEOARTHRITIS", "PAIN", "HIV INFECTION", "DYSMENORRHEA", "OSTEOARTHRITIS, HIP", "RHEUMATOID ARTHRITIS", "TUBERCULOSIS", "ANKYLOSING SPONDYLITIS", "OSTEOARTHRITIS, KNEE"]}, {"indications": [{"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "POST OPERATIVE NAUSEA AND VOMITING", "stage": 3}, {"efo_term": "PERIODONTITIS", "stage": 2}, {"efo_term": "RENAL COLIC", "stage": 1}], "max_phase": 4, "name": "KETOPROFEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL571", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["MYALGIA", "OSTEOARTHRITIS", "ARTHRALGIA", "MIGRAINE DISORDER", "OSTEOARTHRITIS, KNEE", "PAIN", "RHEUMATIC DISEASE", "POST OPERATIVE NAUSEA AND VOMITING", "RENAL COLIC", "PERIODONTITIS"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "ACTINIC KERATOSIS", "stage": 3}, {"efo_term": "MUSCULAR DISEASE", "stage": 3}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "SKIN NEOPLASM", "stage": 2}, {"efo_term": "GOUT", "stage": 2}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "DICLOFENAC SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1034", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["ACTINIC KERATOSIS", "MUSCULAR DISEASE", "OSTEOARTHRITIS", "PAIN", "OSTEOARTHRITIS, KNEE", "SKIN NEOPLASM", "RHEUMATOID ARTHRITIS", "INFLAMMATION", "GOUT"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 3}, {"efo_term": "TUBERCULOSIS", "stage": 3}, {"efo_term": "DYSMENORRHEA", "stage": 2}, {"efo_term": "HEMORRHAGE", "stage": 1}], "max_phase": 4, "name": "MELOXICAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL599", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS", "PAIN", "DYSMENORRHEA", "ANKYLOSING SPONDYLITIS", "TUBERCULOSIS", "RHEUMATIC DISEASE", "RHEUMATOID ARTHRITIS", "HEMORRHAGE"]}, {"indications": [{"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "EYE INFLAMMATION", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 2}, {"efo_term": "RENAL COLIC", "stage": 1}], "max_phase": 4, "name": "PIROXICAM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL527", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "ARTHRALGIA", "EYE INFLAMMATION", "MYALGIA", "RHEUMATOID ARTHRITIS", "OSTEOARTHRITIS", "RHEUMATIC DISEASE", "RENAL COLIC"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "DYSMENORRHEA", "stage": 4}, {"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 4}, {"efo_term": "TENDINOPATHY", "stage": 4}, {"efo_term": "GOUT", "stage": 4}, {"efo_term": "FROZEN SHOULDER", "stage": 4}], "max_phase": 4, "name": "NAPROXEN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200806", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS", "PAIN", "RHEUMATOID ARTHRITIS", "DYSMENORRHEA", "ANKYLOSING SPONDYLITIS", "TENDINOPATHY", "GOUT", "FROZEN SHOULDER"]}, {"indications": [{"efo_term": "EYE INFLAMMATION", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}, {"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "PAIN", "stage": 2}, {"efo_term": "PERIODONTITIS", "stage": 2}], "max_phase": 4, "name": "FLURBIPROFEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL563", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["EYE INFLAMMATION", "MYALGIA", "PAIN", "ARTHRALGIA", "PERIODONTITIS", "RHEUMATIC DISEASE"]}, {"indications": [{"efo_term": "CATARACT", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "MIGRAINE DISORDER", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "PULPITIS", "stage": 2}, {"efo_term": "ALLERGIC RHINITIS", "stage": 1}], "max_phase": 4, "name": "KETOROLAC TROMETHAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201124", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["MIGRAINE DISORDER", "PAIN", "CATARACT", "ALLERGIC RHINITIS", "BREAST CARCINOMA", "PULPITIS"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "PAIN", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 4}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 4}, {"efo_term": "FISH-EYE DISEASE", "stage": 1}], "max_phase": 4, "name": "ETODOLAC", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL622", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "PAIN", "FISH-EYE DISEASE", "OSTEOARTHRITIS", "RHEUMATOID ARTHRITIS"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "OSTEOARTHRITIS, KNEE", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "POLYP", "stage": 2}], "max_phase": 4, "name": "ROFECOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL122", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, KNEE", "POLYP", "OSTEOARTHRITIS", "RHEUMATIC DISEASE"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "PANCREATITIS", "stage": 2}], "max_phase": 4, "name": "VALDECOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL865", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["PAIN", "OSTEOARTHRITIS", "RHEUMATIC DISEASE", "PANCREATITIS"]}, {"indications": [{"efo_term": "CATARACT", "stage": 4}, {"efo_term": "EYE INFLAMMATION", "stage": 4}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 2}, {"efo_term": "MACULAR EDEMA", "stage": 2}], "max_phase": 4, "name": "NEPAFENAC", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1021", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["DIABETIC RETINOPATHY", "CATARACT", "EYE INFLAMMATION", "MACULAR EDEMA"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "EYE INFLAMMATION", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}], "max_phase": 4, "name": "OXYPHENBUTAZONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1228", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "EYE INFLAMMATION", "MYALGIA", "ARTHRALGIA"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "OSTEOARTHRITIS", "stage": 3}, {"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "LIVER DISEASE", "stage": 1}], "max_phase": 3, "name": "NAPROXCINOD", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103831", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "LIVER DISEASE", "OSTEOARTHRITIS", "OSTEOARTHRITIS, HIP"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "MYALGIA", "stage": 4}, {"efo_term": "ARTHRALGIA", "stage": 4}], "max_phase": 4, "name": "PHENYLBUTAZONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL101", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "MYALGIA", "ARTHRALGIA"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "HEMORRHAGE", "stage": 3}, {"efo_term": "DYSMENORRHEA", "stage": 2}], "max_phase": 4, "name": "MEFENAMIC ACID", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL686", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "DYSMENORRHEA", "HEMORRHAGE"]}, {"indications": [{"efo_term": "MIGRAINE DISORDER", "stage": 4}, {"efo_term": "PAIN", "stage": 3}, {"efo_term": "DYSMENORRHEA", "stage": 2}], "max_phase": 4, "name": "DICLOFENAC POTASSIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200804", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["PAIN", "DYSMENORRHEA", "MIGRAINE DISORDER"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS, HIP", "stage": 3}, {"efo_term": "OSTEOARTHRITIS", "stage": 2}], "max_phase": 3, "name": "POLMACOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL166863", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS, HIP", "OSTEOARTHRITIS"]}, {"indications": [{"efo_term": "PANCREATIC CARCINOMA", "stage": 1}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}], "max_phase": 2, "name": "APRICOXIB", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1835207", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["PANCREATIC CARCINOMA", "NON-SMALL CELL LUNG CARCINOMA"]}, {"indications": [{"efo_term": "ANKYLOSING SPONDYLITIS", "stage": 2}, {"efo_term": "NEUROPATHY", "stage": 2}], "max_phase": 4, "name": "SULFASALAZINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL421", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["ANKYLOSING SPONDYLITIS", "NEUROPATHY"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 2}], "max_phase": 4, "name": "SULINDAC", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL15770", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE", "COLORECTAL ADENOCARCINOMA"]}, {"indications": [{"efo_term": "CATARACT", "stage": 2}, {"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "BROMFENAC SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL751", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["CATARACT", "INFLAMMATION"]}, {"indications": [{"efo_term": "FEVER", "stage": 4}, {"efo_term": "PAIN", "stage": 4}], "max_phase": 4, "name": "DIFLUNISAL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL898", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["FEVER", "PAIN"]}, {"indications": [{"efo_term": "PAIN", "stage": 4}, {"efo_term": "BREAST CARCINOMA", "stage": 0}], "max_phase": 4, "name": "DICLOFENAC EPOLAMINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201180", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["PAIN", "BREAST CARCINOMA"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}], "max_phase": 4, "name": "NABUMETONE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1070", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}], "max_phase": 4, "name": "SUPROFEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL956", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE"]}, {"indications": [{"efo_term": "RHEUMATIC DISEASE", "stage": 4}], "max_phase": 4, "name": "OXAPROZIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1071", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["RHEUMATIC DISEASE"]}, {"indications": [{"efo_term": "INFLAMMATION", "stage": 1}], "max_phase": 4, "name": "INDOMETHACIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200864", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["INFLAMMATION"]}, {"indications": [{"efo_term": "PATENT DUCTUS ARTERIOSUS", "stage": 4}], "max_phase": 4, "name": "IBUPROFEN LYSINE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201141", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["PATENT DUCTUS ARTERIOSUS"]}, {"indications": [{"efo_term": "PAIN", "stage": 3}], "max_phase": 4, "name": "IBUPROFEN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1241153", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["PAIN"]}, {"indications": [{"efo_term": "OSTEOARTHRITIS", "stage": 2}], "max_phase": 2, "name": "NAPROXEN ETEMESIL", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2105683", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": ["OSTEOARTHRITIS"]}, {"indications": [], "max_phase": 4, "name": "CARPROFEN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1316", "mechanisms": ["Cyclooxygenase-2 inhibitor"], "genes": ["PTGS2"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "MECLOFENAMATE SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL876", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BISMUTH SUBSALICYLATE", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1120", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OXAPROZIN POTASSIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200463", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMINOSALICYLATE POTASSIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200584", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "TOLMETIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200613", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "BALSALAZIDE DISODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200760", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FLURBIPROFEN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200990", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "OLSALAZINE SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1201013", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "AMINOSALICYLATE SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2096646", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}, {"indications": [], "max_phase": 4, "name": "FENOPROFEN CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2103736", "mechanisms": ["Cyclooxygenase inhibitor"], "genes": ["PTGS2", "PTGS1"], "type": "Small molecule", "diseases": []}], "heat": 0.7464415818666668, "nodes": [{"assoc": 0.2393247456, "id": "ENSG00000059377", "label": "TBXAS1"}, {"assoc": 1.0, "id": "ENSG00000073756", "label": "PTGS2"}, {"assoc": 1.0, "id": "ENSG00000095303", "label": "PTGS1"}], "size": 3}, {"diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "HIV INFECTION", "NEUROFIBROMATOSIS TYPE 1", "CARDIOVASCULAR DISEASE", "BREAST CARCINOMA", "PROSTATE CARCINOMA", "ASTHMA", "RHEUMATOID ARTHRITIS", "RETT SYNDROME", "STROKE", "MELANOMA", "HIV-1 INFECTION", "ALZHEIMERS DISEASE", "DISORDER OF LIPID METABOLISM", "HYPERCHOLESTEROLEMIA", "ATRIAL FIBRILLATION", "COLORECTAL ADENOCARCINOMA", "HYPERLIPIDEMIA", "HYPERTRIGLYCERIDEMIA", "INTRACEREBRAL HEMORRHAGE", "CHOROIDEREMIA", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "HEPATITIS B INFECTION", "PNEUMONIA", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "SMITH-LEMLI-OPITZ SYNDROME", "SUBARACHNOID HEMORRHAGE", "INSOMNIA", "NON-SMALL CELL LUNG CARCINOMA", "SICKLE CELL ANEMIA", "CELIAC DISEASE", "PERIPHERAL ARTERIAL DISEASE", "SEPTIC SHOCK", "TYPE II DIABETES MELLITUS", "PULMONARY HYPERTENSION", "CHRONIC KIDNEY DISEASE", "POLYCYSTIC OVARY SYNDROME", "BIPOLAR DISORDER", "CHRONIC LYMPHOCYTIC LEUKEMIA", "GASTRIC CARCINOMA", "SEPSIS", "VITILIGO", "SINUSITIS", "ABNORMALITY OF LIPID METABOLISM", "FAMILIAL HYPERCHOLESTEROLEMIA", "MYOCARDIAL INFARCTION", "DIABETIC RETINOPATHY", "ALOPECIA AREATA", "HEART FAILURE", "MACROGLOBULINEMIA", "SMOKING CESSATION", "INFLAMMATION", "PERIODONTITIS", "CIRRHOSIS OF LIVER", "PARKINSON'S DISEASE", "RECTUM CANCER", "UVEITIS", "CANCER", "COMBINED HYPERLIPIDEMIA", "MULTIPLE SCLEROSIS", "PROSTATE ADENOCARCINOMA", "VASCULAR DISEASE", "CORONARY ARTERY DISEASE", "DIABETES MELLITUS", "PREECLAMPSIA", "STRICTURE", "KIDNEY DISEASE", "SARCOIDOSIS", "CORONARY HEART DISEASE", "PSORIASIS", "ACUTE CORONARY SYNDROME", "ACUTE GRAFT VS. HOST DISEASE", "METABOLIC SYNDROME", "HYPERTROPHIC CARDIOMYOPATHY", "INFLUENZA INFECTION", "SYSTEMIC LUPUS ERYTHEMATOSUS", "MUCOCUTANEOUS LYMPH NODE SYNDROME", "TYPE I DIABETES MELLITUS", "BREAST NEOPLASM", "RENAL INSUFFICIENCY", "HYPERTENSION", "NON-ALCOHOLIC FATTY LIVER DISEASE", "NASOPHARYNGEAL NEOPLASM", "SYSTEMIC SCLERODERMA", "ENDOMETRIAL NEOPLASM", "CELL DEATH"], "links": [{"source": "ENSG00000101856", "target": "ENSG00000186480"}, {"source": "ENSG00000113161", "target": "ENSG00000186480"}], "drugs": [{"indications": [{"efo_term": "HYPERCHOLESTEROLEMIA", "stage": 4}, {"efo_term": "HYPERLIPIDEMIA", "stage": 4}, {"efo_term": "CORONARY ARTERY DISEASE", "stage": 4}, {"efo_term": "CORONARY HEART DISEASE", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "FAMILIAL HYPERCHOLESTEROLEMIA", "stage": 4}, {"efo_term": "ABNORMALITY OF LIPID METABOLISM", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "HEART FAILURE", "stage": 4}, {"efo_term": "HYPERTENSION", "stage": 4}, {"efo_term": "COMBINED HYPERLIPIDEMIA", "stage": 3}, {"efo_term": "DISORDER OF LIPID METABOLISM", "stage": 3}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "PREECLAMPSIA", "stage": 3}, {"efo_term": "KIDNEY DISEASE", "stage": 3}, {"efo_term": "HYPERTRIGLYCERIDEMIA", "stage": 3}, {"efo_term": "PSORIASIS", "stage": 3}, {"efo_term": "ACUTE CORONARY SYNDROME", "stage": 3}, {"efo_term": "METABOLIC SYNDROME", "stage": 3}, {"efo_term": "HYPERTROPHIC CARDIOMYOPATHY", "stage": 3}, {"efo_term": "SYSTEMIC LUPUS ERYTHEMATOSUS", "stage": 3}, {"efo_term": "RENAL INSUFFICIENCY", "stage": 3}, {"efo_term": "CELL DEATH", "stage": 3}, {"efo_term": "ASTHMA", "stage": 2}, {"efo_term": "CANCER", "stage": 2}, {"efo_term": "MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 2}, {"efo_term": "PROSTATE ADENOCARCINOMA", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "VASCULAR DISEASE", "stage": 2}, {"efo_term": "DIABETES MELLITUS", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "HIV-1 INFECTION", "stage": 2}, {"efo_term": "SARCOIDOSIS", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "ACUTE GRAFT VS. HOST DISEASE", "stage": 2}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "INFLUENZA INFECTION", "stage": 2}, {"efo_term": "PERIODONTITIS", "stage": 2}, {"efo_term": "TYPE I DIABETES MELLITUS", "stage": 2}, {"efo_term": "BREAST NEOPLASM", "stage": 2}, {"efo_term": "VITILIGO", "stage": 2}, {"efo_term": "NON-ALCOHOLIC FATTY LIVER DISEASE", "stage": 2}, {"efo_term": "NASOPHARYNGEAL NEOPLASM", "stage": 2}, {"efo_term": "SYSTEMIC SCLERODERMA", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "STRICTURE", "stage": 1}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 1}, {"efo_term": "INSOMNIA", "stage": 1}, {"efo_term": "MUCOCUTANEOUS LYMPH NODE SYNDROME", "stage": 1}, {"efo_term": "ENDOMETRIAL NEOPLASM", "stage": 0}], "max_phase": 4, "name": "ATORVASTATIN CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL393220", "mechanisms": ["HMG-CoA reductase inhibitor"], "genes": ["HMGCR"], "type": "Small molecule", "diseases": ["ASTHMA", "CANCER", "COMBINED HYPERLIPIDEMIA", "DISORDER OF LIPID METABOLISM", "HYPERCHOLESTEROLEMIA", "HYPERLIPIDEMIA", "MULTIPLE SCLEROSIS", "POLYCYSTIC OVARY SYNDROME", "PROSTATE ADENOCARCINOMA", "PULMONARY HYPERTENSION", "VASCULAR DISEASE", "CHRONIC KIDNEY DISEASE", "CORONARY ARTERY DISEASE", "DIABETES MELLITUS", "PREECLAMPSIA", "SEPSIS", "STRICTURE", "HIV-1 INFECTION", "KIDNEY DISEASE", "SARCOIDOSIS", "BREAST CARCINOMA", "COLORECTAL ADENOCARCINOMA", "CORONARY HEART DISEASE", "HIV INFECTION", "HYPERTRIGLYCERIDEMIA", "PSORIASIS", "ACUTE CORONARY SYNDROME", "ACUTE GRAFT VS. HOST DISEASE", "CARDIOVASCULAR DISEASE", "METABOLIC SYNDROME", "ALZHEIMERS DISEASE", "HYPERTROPHIC CARDIOMYOPATHY", "INFLUENZA INFECTION", "SYSTEMIC LUPUS ERYTHEMATOSUS", "FAMILIAL HYPERCHOLESTEROLEMIA", "INSOMNIA", "MUCOCUTANEOUS LYMPH NODE SYNDROME", "PERIODONTITIS", "TYPE I DIABETES MELLITUS", "BREAST NEOPLASM", "ABNORMALITY OF LIPID METABOLISM", "MYOCARDIAL INFARCTION", "RENAL INSUFFICIENCY", "VITILIGO", "HEART FAILURE", "HYPERTENSION", "NON-ALCOHOLIC FATTY LIVER DISEASE", "NASOPHARYNGEAL NEOPLASM", "SYSTEMIC SCLERODERMA", "BIPOLAR DISORDER", "ENDOMETRIAL NEOPLASM", "CELL DEATH"]}, {"indications": [{"efo_term": "HYPERCHOLESTEROLEMIA", "stage": 4}, {"efo_term": "HYPERLIPIDEMIA", "stage": 4}, {"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "ABNORMALITY OF LIPID METABOLISM", "stage": 4}, {"efo_term": "FAMILIAL HYPERCHOLESTEROLEMIA", "stage": 4}, {"efo_term": "MYOCARDIAL INFARCTION", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 3}, {"efo_term": "DISORDER OF LIPID METABOLISM", "stage": 3}, {"efo_term": "COLORECTAL ADENOCARCINOMA", "stage": 3}, {"efo_term": "HYPERTRIGLYCERIDEMIA", "stage": 3}, {"efo_term": "PNEUMONIA", "stage": 3}, {"efo_term": "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "stage": 3}, {"efo_term": "SUBARACHNOID HEMORRHAGE", "stage": 3}, {"efo_term": "ASTHMA", "stage": 3}, {"efo_term": "CHRONIC KIDNEY DISEASE", "stage": 3}, {"efo_term": "POLYCYSTIC OVARY SYNDROME", "stage": 3}, {"efo_term": "GASTRIC CARCINOMA", "stage": 3}, {"efo_term": "DIABETIC RETINOPATHY", "stage": 3}, {"efo_term": "INFLAMMATION", "stage": 3}, {"efo_term": "ALZHEIMERS DISEASE", "stage": 2}, {"efo_term": "ATRIAL FIBRILLATION", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "INTRACEREBRAL HEMORRHAGE", "stage": 2}, {"efo_term": "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "stage": 2}, {"efo_term": "SMITH-LEMLI-OPITZ SYNDROME", "stage": 2}, {"efo_term": "SICKLE CELL ANEMIA", "stage": 2}, {"efo_term": "SEPTIC SHOCK", "stage": 2}, {"efo_term": "PULMONARY HYPERTENSION", "stage": 2}, {"efo_term": "BIPOLAR DISORDER", "stage": 2}, {"efo_term": "SEPSIS", "stage": 2}, {"efo_term": "VITILIGO", "stage": 2}, {"efo_term": "SINUSITIS", "stage": 2}, {"efo_term": "MACROGLOBULINEMIA", "stage": 2}, {"efo_term": "SMOKING CESSATION", "stage": 2}, {"efo_term": "PERIODONTITIS", "stage": 2}, {"efo_term": "CIRRHOSIS OF LIVER", "stage": 2}, {"efo_term": "PARKINSON'S DISEASE", "stage": 2}, {"efo_term": "RECTUM CANCER", "stage": 2}, {"efo_term": "UVEITIS", "stage": 2}, {"efo_term": "CHOROIDEREMIA", "stage": 1}, {"efo_term": "HEPATITIS B INFECTION", "stage": 1}, {"efo_term": "INSOMNIA", "stage": 1}, {"efo_term": "NON-SMALL CELL LUNG CARCINOMA", "stage": 1}, {"efo_term": "CELIAC DISEASE", "stage": 1}, {"efo_term": "TYPE II DIABETES MELLITUS", "stage": 1}, {"efo_term": "HIV INFECTION", "stage": 1}, {"efo_term": "CHRONIC LYMPHOCYTIC LEUKEMIA", "stage": 1}, {"efo_term": "ALOPECIA AREATA", "stage": 1}, {"efo_term": "PERIPHERAL ARTERIAL DISEASE", "stage": 0}, {"efo_term": "HEART FAILURE", "stage": 0}], "max_phase": 4, "name": "SIMVASTATIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1064", "mechanisms": ["HMG-CoA reductase inhibitor"], "genes": ["HMGCR"], "type": "Small molecule", "diseases": ["ALZHEIMERS DISEASE", "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "DISORDER OF LIPID METABOLISM", "HYPERCHOLESTEROLEMIA", "ATRIAL FIBRILLATION", "BREAST CARCINOMA", "COLORECTAL ADENOCARCINOMA", "HYPERLIPIDEMIA", "HYPERTRIGLYCERIDEMIA", "INTRACEREBRAL HEMORRHAGE", "CARDIOVASCULAR DISEASE", "CHOROIDEREMIA", "CHRONIC PROGRESSIVE MULTIPLE SCLEROSIS", "HEPATITIS B INFECTION", "PNEUMONIA", "RELAPSING-REMITTING MULTIPLE SCLEROSIS", "SMITH-LEMLI-OPITZ SYNDROME", "SUBARACHNOID HEMORRHAGE", "INSOMNIA", "NON-SMALL CELL LUNG CARCINOMA", "SICKLE CELL ANEMIA", "ASTHMA", "CELIAC DISEASE", "PERIPHERAL ARTERIAL DISEASE", "SEPTIC SHOCK", "TYPE II DIABETES MELLITUS", "PULMONARY HYPERTENSION", "CHRONIC KIDNEY DISEASE", "HIV INFECTION", "POLYCYSTIC OVARY SYNDROME", "BIPOLAR DISORDER", "CHRONIC LYMPHOCYTIC LEUKEMIA", "GASTRIC CARCINOMA", "SEPSIS", "VITILIGO", "SINUSITIS", "ABNORMALITY OF LIPID METABOLISM", "FAMILIAL HYPERCHOLESTEROLEMIA", "MYOCARDIAL INFARCTION", "DIABETIC RETINOPATHY", "ALOPECIA AREATA", "HEART FAILURE", "MACROGLOBULINEMIA", "SMOKING CESSATION", "INFLAMMATION", "PERIODONTITIS", "CIRRHOSIS OF LIVER", "PARKINSON'S DISEASE", "RECTUM CANCER", "UVEITIS"]}, {"indications": [{"efo_term": "CARDIOVASCULAR DISEASE", "stage": 4}, {"efo_term": "CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "stage": 2}, {"efo_term": "HIV INFECTION", "stage": 2}, {"efo_term": "NEUROFIBROMATOSIS TYPE 1", "stage": 2}, {"efo_term": "BREAST CARCINOMA", "stage": 2}, {"efo_term": "PROSTATE CARCINOMA", "stage": 2}, {"efo_term": "RHEUMATOID ARTHRITIS", "stage": 2}, {"efo_term": "RETT SYNDROME", "stage": 2}, {"efo_term": "MELANOMA", "stage": 2}, {"efo_term": "ASTHMA", "stage": 1}, {"efo_term": "STROKE", "stage": 1}], "max_phase": 4, "name": "LOVASTATIN", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL503", "mechanisms": ["HMG-CoA reductase inhibitor"], "genes": ["HMGCR"], "type": "Small molecule", "diseases": ["CHRONIC OBSTRUCTIVE PULMONARY DISEASE", "HIV INFECTION", "NEUROFIBROMATOSIS TYPE 1", "CARDIOVASCULAR DISEASE", "BREAST CARCINOMA", "PROSTATE CARCINOMA", "ASTHMA", "RHEUMATOID ARTHRITIS", "RETT SYNDROME", "STROKE", "MELANOMA"]}, {"indications": [{"efo_term": "HYPERCHOLESTEROLEMIA", "stage": 3}, {"efo_term": "FAMILIAL HYPERCHOLESTEROLEMIA", "stage": 3}, {"efo_term": "DISORDER OF LIPID METABOLISM", "stage": 1}], "max_phase": 4, "name": "ROSUVASTATIN CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1744447", "mechanisms": ["HMG-CoA reductase inhibitor"], "genes": ["HMGCR"], "type": "Small molecule", "diseases": ["DISORDER OF LIPID METABOLISM", "HYPERCHOLESTEROLEMIA", "FAMILIAL HYPERCHOLESTEROLEMIA"]}, {"indications": [{"efo_term": "ABNORMALITY OF LIPID METABOLISM", "stage": 4}, {"efo_term": "HYPERLIPIDEMIA", "stage": 4}], "max_phase": 4, "name": "PITAVASTATIN CALCIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1237061", "mechanisms": ["HMG-CoA reductase inhibitor"], "genes": ["HMGCR"], "type": "Small molecule", "diseases": ["ABNORMALITY OF LIPID METABOLISM", "HYPERLIPIDEMIA"]}, {"indications": [{"efo_term": "HIV-1 INFECTION", "stage": 2}], "max_phase": 4, "name": "PRAVASTATIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL690", "mechanisms": ["HMG-CoA reductase inhibitor"], "genes": ["HMGCR"], "type": "Small molecule", "diseases": ["HIV-1 INFECTION"]}, {"indications": [{"efo_term": "BREAST CARCINOMA", "stage": 2}], "max_phase": 4, "name": "FLUVASTATIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL2218894", "mechanisms": ["HMG-CoA reductase inhibitor"], "genes": ["HMGCR"], "type": "Small molecule", "diseases": ["BREAST CARCINOMA"]}, {"indications": [], "max_phase": 4, "name": "CERIVASTATIN SODIUM", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL1200563", "mechanisms": ["HMG-CoA reductase inhibitor"], "genes": ["HMGCR"], "type": "Small molecule", "diseases": []}], "heat": 0.4167689152444333, "nodes": [{"assoc": 0.0623278333333, "id": "ENSG00000101856", "label": "PGRMC1"}, {"assoc": 1.0, "id": "ENSG00000113161", "label": "HMGCR"}, {"assoc": 0.1879789124, "id": "ENSG00000186480", "label": "INSIG1"}], "size": 3}, {"diseases": [], "links": [{"source": "ENSG00000109424", "target": "ENSG00000175564"}, {"source": "ENSG00000109424", "target": "ENSG00000175567"}, {"source": "ENSG00000175564", "target": "ENSG00000175567"}], "drugs": [], "heat": 0.0866915300037, "nodes": [{"assoc": 0.1972956039, "id": "ENSG00000109424", "label": "UCP1"}, {"assoc": 0.015124, "id": "ENSG00000175564", "label": "UCP3"}, {"assoc": 0.0476549861111, "id": "ENSG00000175567", "label": "UCP2"}], "size": 3}], "auto_delta": "0.00268996"}